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Abstract 
Design and validation of a mathematical model to describe macrophage dynamics in 
wound healing 
Tony Yu 
Kara Spiller, PhD. 
 
 
 
 
Macrophages have been shown to play an essential role in regulating the foreign 
body response, and understanding and modulating the macrophage dynamics in wound 
healing could potentially help overcome their ability to impair biomaterial performance. 
However, in vivo animal studies are often utilized to study the macrophage dynamics, 
which are costly and time consuming. Although there have been previous models that 
describe the macrophage behavior and the foreign body response, many of the parameters 
of these models were not based on experiments and are not physiologically relevant to 
macrophage biology. Therefore, there is a need to develop a model that can help predict 
the in vivo foreign body response in wound healing based on in vitro and/or in vivo 
experiments. In this study, a mathematical model was developed to describe the 
macrophage dynamics (M0, M1, and M2) in normal wound healing based on cell 
viability and flow cytometry experiments of unactivated and polarized macrophages 
cultured in vitro. The ordinary differential equations that describe the macrophage 
populations take into consideration the polarization, transition, and proliferation of 
surviving macrophages within each population, resulting in an accurate description of 
macrophage biology.  
 
xv 
 
This mathematical model was then applied to describe macrophage dyanmics an 
in vivo study of the macrophage response to implanted biomaterials, which have often 
been described as chronic wounds. Gelatin hydrogels, crosslinked to different extents, 
were used as model biomaterials. The hydrogels were characterized for properties 
including mechanical stiffness, degradation, swelling, and crosslinking density, and were 
implanted subcutaneously in C57BL/6 mice for 3 day, 10 days, and 3 weeks. H&E, 
Masson’s trichrome, and immunohistochemistry were performed on these samples to 
quantify the thickness of the fibrous capsule and the relative proportions of different 
macrophage populations.  
 
The mathematical model was able to describe the macrophage profiles that were 
consistent with normal wound healing. In this model, an initial inflammatory response 
was observed, followed by an accumulation of M2 macrophages over time. The 
implanted hydrogels imposed a chronic inflammation throughout the study with a 
constant infiltration of M1 macrophages. The M2 macrophages behaved in a similar 
manner to that of normal wound healing, with a slow and gradual accumulation of M2 
macrophages over time. The M1:M2 ratio indicated a dominant M1 phenotype at the 
early time point. At the later time point, a ratio of 1 indicated an even distribution of M1 
and M2 macrophages. Correlation analyses showed that the M2 macrophages were 
strongly correlated with fibrous capsule thickness. Thus, the mathematical model 
developed here can be used to increase our understanding of macrophage dynamics in 
wound healing and response to biomaterials. 
1 
 
Chapter 1: Introduction 
Biomaterials are part of the solution to many unmet clinical needs, from 
implantable sensors to drug delivery devices and engineered tissues. However, 
biomaterials face an inflammatory environment upon implantation, which represents a 
potential obstacle to their success [1].  In this chapter, we review the consequences of the 
foreign body response (FBR) for biomaterial function, and strategies that have been used 
to inhibit the FBR. We focus on the role of the macrophage, the cell at the center of the 
inflammatory response, as the major regulator of the FBR, and discuss implications of 
changing macrophage behavior on biomaterial acceptance or rejection. Finally, we 
discuss recent discoveries in the role of macrophage phenotype, ranging from pro-
inflammatory (M1) to anti-inflammatory (M2), and the role it plays in wound healing and 
biomaterial vascularization and integration. We conclude with a discussion of biomaterial 
design strategies that have been suggested to positively interact with and potentially 
control macrophages in order to improve interactions between biomaterials and the 
inflammatory response.  
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Figure 1:  Progression of the foreign body response. Upon implantation of the biomaterial (A) proteins from the 
blood and tissue nonspecifically adsorb to the biomaterial surface (B), and the coagulation cascade is initiated 
(C). Neutrophils and monocytes are recruited during the acute inflammatory phase (D). Monocytes differentiate 
into macrophages which attempt to degrade the biomaterial. If the macrophages cannot degrade the material 
they fuse into foreign body giant cells, the hallmark of chronic inflammation (E). These multinucleated cells 
stimulate formation of granulation tissue, which eventually becomes a dense fibrous collagen capsule that 
isolates the biomaterial from the rest of the body (F). 
  
1.1 The foreign body response and consequences for implanted biomaterials 
 Upon implantation (Fig. 1a), the body mounts the FBR against the biomaterial, 
beginning with protein adsorption to the biomaterial surface (Fig. 1b) [2]. This creates a 
thrombogenic surface and results in the activation and aggregation of a platelet-fibrin 
meshwork (Fig. 1c) [3]. The resulting pro-coagulant surface results in the infiltration of 
inflammatory cells. Neutrophils are the first inflammatory cells to arrive at the 
biomaterial surface [4]. When these cells are unable to phagocytose the foreign body, 
cytokines are released, which result in the differentiation of macrophages from 
monocytes [5]. Of the recruited immune cells, macrophages are the main cell type that 
regulates the FBR. At this point in normal wound healing, the acute inflammation phase 
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(Fig. 1d) would ebb and proliferation of fibroblasts and eventually remodeling of the 
wound would occur [4]. However, in response to an implanted biomaterial the 
macrophages continue to attempt to remove the foreign body via phagocytosis and 
secrete enzymes and reactive species that aggravate the inflammatory state [6]. As a 
result, the progression through normal wound healing is disturbed and a chronic 
inflammation phase ensues (Fig. 1e) [7]. If the biomaterial cannot be degraded, the 
macrophages fuse together to form multinucleated foreign body giant cells (FBGC) that 
surround the biomaterial [8]. FBGCs and recruited fibroblasts deposit collagen layers 
around the biomaterial to form granulation tissues [9]. Over time, the granulation tissue 
becomes a dense collagen capsule, the hallmark of the FBR (Fig. 1f) [9]. Isolation of the 
biomaterial within this capsule as well as the secretion of damaging enzymes jeopardizes 
the functioning of the biomaterial. Some biomaterial applications that are particularly 
sensitive to the FBR include drug delivery devices, sensory devices, electrical devices, 
and tissue engineered constructs. 
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Figure 2: Biomaterials particularly sensitive to the foreign body response. A. Glial scarring in around implanted 
microelectrodes can block the conductance of neuronal activity. B. Vascularization, critical for the functionality 
of some implants, is blocked by fibrous encapsulation. C. The fibrous capsule acts as a diffusion barrier, 
decreasing the performance of diffusion-dependent biomaterials such as drug delivery devices and glucose 
sensors. 
  
 1.1.1 Diffusion-dependent biomedical devices 
Biomaterials that depend on diffusion of molecules for their function include drug 
delivery systems, which are used to locally delivery drugs or growth factors to a 
particular area of the body, and sensors that measure the level of a molecule in the blood 
or tissue, including glucose sensors (Figure 2a). Fibrous encapsulation can hinder 
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diffusion, thus adversely affecting the function of the biomaterial [10]. For example, 
Anderson et al. investigated the drug release of gentamicin, an antibiotic, from silicone 
rubber rods [11]. Liquid-scintillation counting was performed to determine the release of 
radiolabeled gentamicin as well as the concentration in tissues adjacent to the implant. 
The rods were coated with a layer of silicon rubber to reduce the initial burst release and 
to prolong the drug release over time. The silicon rod drug release system with different 
gentamicin loading dosages (20, 35, and 40 wt%) were implanted intramuscularly at the 
thigh muscles in dogs for 1 day, 1, 2, and 4 weeks. A fibrous capsule of about 5 um and 
11-15 um thick was observed at 2 and 4 weeks post-implantation, respectively. Along 
with the observation of connective tissues forming around the implants, a reduction of the 
drug release rate was observed over the 4 week period. In addition, the difference in the 
gentamicin tissue level and serum levels over the first 3 weeks indicated that there was 
another factor with a different diffusion coefficient that may be responsible for the 
reduction in the drug release rate. As a result, it was suggested that formation of the 
fibrous capsule inhibited the release of gentamicin [11].   
One of the most common medical devices to monitor diabetes is the continuous 
glucose monitor (CGM), which monitors the blood glucose level via diffusion of blood 
glucose to the glucose sensor [12]. The FBR can hinder this function, as is demonstrated 
by a study in which macrophage depletion with diphtheria toxin driven by the CD11b 
promoter improved sensor performance [13]. While the creation of a diffusion barrier by 
the fibrous capsule likely inhibits sensor performance, it may also be a result of 
macrophage metabolic activity [14]. Klueh et al. injected macrophages at the 
implantation site of glucose sensors in mice [12]. The macrophages surrounded the 
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sensors and sensor output quickly diminished, an effect that was not observed with 
injected lymphocytes. Interestingly, when serum glucose levels were artificially elevated, 
they were detected by the sensors, suggesting that their function was not permanently 
impaired by the presence of the macrophages. Moreover, companion in vitro studies 
showed that the presence of macrophages without the fibrous capsule or other biofouling 
effects also hindered sensor performance. The authors concluded that metabolism of 
glucose by macrophages also contribute to decreased sensor performance [12]. 
 
1.1.2 Transmission of electrical signals 
Some medical devices require the conductance of electrical signals in order to 
monitor or pace the electrical activity of the brain, heart, or other muscles in the body, but 
the transmission of these signals can be inhibited by the presence of a fibrous capsule or a 
glial scar, as is the case in the central nervous system (Figure 2b) [15]. A common 
electrical recording device is the silicon microelectrode array, a technology that measures 
the neuronal activity in the brain that is often used to monitor the activity of neurons 
and/or to investigate the correlation between the brain activity and behavior. However, 
one of the main limitations of this technology is inconsistency of performance in long 
term applications. In a study by Biran et al. [16], the silicon microelectrode array was 
implanted into the brains of rats for 2 and 4 weeks to determine the mechanism of failures 
of the microelectrode arrays. Stab wounds were also created with the same 
microelectrodes as controls in order to distinguish whether it was the initial penetrating 
trauma or the FBR to the chronically implanted microelectrodes that caused device 
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failure. After 2 and 4 weeks post-implantation, immunohistochemical analysis of the 
brain tissue indicated multilayered and dense regions of ED1-positive cells, a pan-
macrophage marker in rats, along the implant-brain tissue interface in both the stab 
wounds and implanted microelectrodes.  However, there were more ED1-positive cells 
surrounding the implanted microelectrodes compared to the stab wound. The intensity of 
glial fibrillary acidic proteins (GFAP) expression by reactive astrocytes was also 
significantly higher surrounding implanted microelectrodes compared to the control stab 
wounds. There was a significant amount of neuronal loss 2 weeks post-implantation in 
the nearby tissue of the implanted microelectrodes compared to the stab wound. Explants 
were rinsed with PBS and cultured in media for 24 hours to assess cytokine secretion by 
adherent macrophages, which showed secretions of the inflammatory cytokines tumor 
necrosis factor-alpha (TNF- α) and monocyte chemotactic protein (MCP-1). Thus, the 
presence of the foreign body increased inflammation, leading to neuronal loss and device 
failure [16]. 
  
 1.1.3 Vascularization and integration of biomaterials   
Tissue engineering holds tremendous potential to replace damaged tissues and organs. 
The success of most tissue engineered constructs requires recruitment of endothelial cells 
and formation of new blood vessels to provide nutrient and oxygen transport for 
implanted cells [17, 18]. However, the FBR and the fibrous capsule prevent direct contact 
between the biomaterial and the surrounding tissue, so that vascularization and 
integration are essentially blocked (Figure 2c). Shin et al. showed that fibrous 
encapsulation of hydrogels based on oligo(poly(ethylene glyocol) fumarate) effectively 
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prevented bone formation and vascularization in a rabbit bone defect model [19]. More 
recently, several studies have confirmed inverse correlation between fibrous capsule 
thickness and blood vessel ingrowth [5, 20].  
 
1.2 Strategies to inhibit the FBR 
Clearly, the FBR and the formation of the fibrous capsule can drastically inhibit the 
function of biomaterials.  Thus, researchers have turned to the development of strategies 
to inhibit the FBR. Because the FBR begins with protein adsorption and inflammatory 
cell interactions at the biomaterial surface, most strategies are based on modifications of 
the biomaterial surface [21, 22]. The main strategies include inhibition of protein 
adsorption, the use of bioactive coatings, and modifications to surface topography. 
 
1.2.1 Inhibition of protein adsorption 
Because the FBR begins with protein adsorption, inhibition of protein adsorption 
has been extensively researched as a tool to inhibit the FBR [23]. PEGylation, hydrogel 
coatings, plasma treatment, and other methods have shown substantially decreased 
protein adsorption in vitro with reduced fibrous capsule formation in vivo [24]. 
Ultimately, however, the sensors fail because blood proteins can still adsorb to a certain 
extent [14]. Recently, ultra-low fouling biomaterials have been prepared from 
zwitterionic materials [21]. Zwitterionic materials have both a positive and negative 
charge that are not dissociated in an aqueous environment. This property attracts water 
molecules via charge-dipole interactions resulting in extremely hydrophilic properties 
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[25]. Thus, adsorption of relatively hydrophobic proteins is drastically reduced. The 
zwitterion carboxybetaine was shown to adsorb <0.3 ng/cm
2
 proteins from 100% blood 
serum, much lower than the 5 ng/cm
2
 of absorbed fibrinogen that is required to initiate 
platelet adhesion [22]. When zwitterionic hydrogels based on poly(carboxybetaine 
methacrylate) (PCBMA) were implanted subcutaneously in mice for 3 months, the 
number of pro-inflammatory macrophages was reduced compared to control hydrogels 
prepared from  poly(2-hydroxyethyl methacrylate) (PHEMA), and the presence of a 
fibrous capsule was not observed [21].  
Thus, inhibition of protein adsorption is an effective way to mitigate the FBR. 
However, without protein adhesion, cells from the body also cannot infiltrate the 
material, so these biomaterials may not be appropriate for applications that require 
integration with the body, such as in tissue engineering. Nonetheless, they may be 
extremely useful for applications in which the biomaterials are not intended to integrate 
with body, such as catheters. 
 
1.2.2 Surface modification with bioactive coatings  
For biomaterials that are intended to integrate with the body, another strategy to 
mitigate the FBR and the formation of the fibrous capsule is to make the biomaterial 
appear less foreign to immune cells, such as by coating with extracellular matrix (ECM)-
derived molecules [26]. The ECM is mainly composed of collagen type I and 
glycosaminoglycans (GAG) such as hyaluronan (HA), chondroitin sulfate, and dermatan 
sulfate. Coating titanium rods with collagen chondroitin sulfate has been shown to inhibit 
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fibrous encapsulation and to promote new bone formation in rat tibial defects [27]. 
Similarly, drug delivery strategies that actively increase integration with the body show 
decreased fibrous capsule formation. For example, controlled release of VEGF and nitric 
oxide (NO) from sensors has been shown to increase vascularization and decrease fibrous 
capsule formation [28, 29]. Controlled release of anti-inflammatory drugs such as 
dexamethasone has also been shown to reduce the FBR to sensors [30]. 
 
1.2.3 Surface topography   
Modifications to the surface topography of biomaterials have also been shown to 
affect the FBR [31]. The addition of porous poly(lactic acid) (PLA) coatings to glucose 
sensors decreased fibrous capsule thickness and increased vascularity following murine 
implantation [32]. Cao et al. investigated the orientation of the topography of electrospun 
nanofibrous poly(caprolactone) (PCL) scaffolds and reported the effect on the FBR [31]. 
The PCL was deposited in three distinct manners: aligned fibers, randomly oriented 
fibers, and a thin film; the scaffolds were then compared to an RGD-coated glass slide as 
a control. IL-4 was added to human monocytes in vitro at days 3 and 7 in order to induce 
the formation of FBGC, mimicking the FBR in vivo. At day 10, the random fiber 
scaffolds resulted in the highest levels of cell attachment compared to the other scaffolds. 
In general, the cell density of all surfaces decreased over time as the macrophages fused 
into FBGC in the presences of IL-4. When the PCL scaffolds were implanted in Sprague-
Dawley rats for 1, 2, and 4 weeks, the random fiber scaffold elicited a more severe FBR 
compared to the other scaffolds, while the aligned fiber scaffold resulted in the thinnest 
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fibrous capsule [31]. Thus, biomaterial topography affects the FBR, and this behavior can 
be studied using in vitro models of macrophage-biomaterial interactions.  
This relationship between in vitro and in vivo results was not supported in another 
study of the effects of biomaterial topography on the FBR. Expanded 
polytetrafluoroethylene (ePTFE) membranes with pore sizes of 0.2, 1, and 3 um were 
seeded with primary human monocytes in vitro and compared to tissue culture 
polystyrene as a control [33]. Membranes with 3um pore size elicited a significant 
increase in the secretion of the inflammatory cytokine interleukin-1-beta (IL1-β) 
compared to the other pore sizes. The ePFTE biomaterials were also implanted 
subcutaneously in mice for 4 weeks to evaluate the formation of the fibrous capsule. 
Interestingly, despite showing more inflammatory activity in vitro, ePTFE membranes 
with 3um pores resulted in a significantly thinner fibrous capsule than the non-porous 
ePTFE [33]. Although these findings did show that biomaterial topography affects the 
FBR, they also highlight the complexity of the relationship between inflammatory cell-
biomaterial interactions and the FBR.  
While the studies of the effects of biomaterial surface topography on the FBR 
have been largely empirical, they do suggest that modulation of topography may be a 
potential tool for mitigating the FBR. More systematic analyses are required to determine 
the mechanism of topographical effects on macrophage behavior and the FBR. 
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1.3 Macrophage biology 
It has been shown through many studies that macrophages play a crucial role in 
regulating the FBR [5].  A better understanding of macrophage dynamics may be the key 
to overcoming their ability to impair biomaterial performance. To understand the 
behavior of macrophages in response to biomaterials, it is helpful to consider biomaterial 
implantation as a chronic wound. Then, the behavior of macrophages can be assessed in 
comparison to normal wound healing in order to discover the mechanisms of impaired 
healing.  
 
 
 
 
 
Figure 3: Macrophages in normal wound healing. A. In normal wound healing, macrophages initially express a 
pro-inflammatory response but as time progress they transition to a pro-healing response. B. Macrophages can 
be polarized into a spectrum of phenotypes that range from a pro-inflammatory to a pro-healing response. 
Those discussed here include: M1 macrophages which are induced through by TNF-α and LPS, M2a 
macrophages which are stimulated by IL-4, and M2c macrophages which are activated by IL-10. 
  
1.3.1 Macrophage phenotypes in normal wound healing  
Normal wound healing in response to an injury generally consists of four distinct 
stages: hemostasis, the inflammatory stage, the proliferation stage, and the remodeling 
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stage [4, 34, 35]. Macrophages can be polarized into a spectrum of phenotypes ranging 
from pro-inflammatory to anti-inflammatory and pro-healing depending on the 
environmental stimulus [36]. Pro-inflammatory macrophages are often referred to as 
“classically activated”, or M1, while the anti-inflammatory macrophages are referred to 
as “alternatively activated”, or M2 phenotype, following the T helper cell nomenclature 
of Th1 and Th2 [36]. At early stages of normal wound healing, M1 macrophages 
infiltrate the wound to promote inflammation and to stimulate the wound healing process 
(Figure 3). M2 macrophages begin to accumulate around day 3 or 4 post-injury, while the 
level of M1 macrophages decreases [36]. M2 macrophages may accumulate via the direct 
transition of M1 to M2, the polarization of newly arriving macrophages to M2, and 
proliferation of other M2 macrophages [37].  The accumulated macrophages eventually 
emigrate to the draining lymph nodes returning back to the pre-injury state of resident 
macrophages after the wound is completely remodeled and healed [38].  
Macrophages have been widely recognized as major regulators of wound healing 
and tissue regeneration over the last few decades. However, much of macrophage biology 
is still not well understood. Although the classification of the different macrophage 
phenotypes is widely accepted, a consensus has not yet been reached as to the overall 
effects and consequences of the diverse macrophages phenotypes on wound healing.  
 
1.3.2 The role of M1 macrophages in wound healing  
Macrophages are polarized to the M1 phenotype by proinflammatory stimuli and 
cytokines such as bacterial lipopolysaccharide (LPS), tumor necrosis factor-alpha (TNF-
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α), and interferon-gamma (IFN-γ) (Figure 3b) [5]. M1 macrophages attempt to 
phagocytose any bacteria, cellular debris, and foreign invaders. However, controversies 
surround the role of M1 macrophages in wound healing. On the one hand, chronic 
inflammation, characterized by persistent numbers of M1 macrophages, is known to 
impair wound healing. For example, Kigerl et al. studied the effect of macrophage 
activation on central nervous system injury of C57BL/6 mice [39]. Moderate midthoracic 
spinal cord injury (SCI) was inflicted on the mice, while the sham mice receive a 
laminectomy without SCI. The tissues samples were collected at day 1, 3, 7, 14, and 28 
post-SCI for immunohistochemical analysis. M1 macrophages were predominant at the 
sites of SCI as indicated by CD86 staining. The RNA from each of the wound sites at 
each time point was extracted for gene expression and showed that the genes associated 
with the M2 macrophages returned to pre-injury level at day 7 post-SCI, while genes 
associated with the M1 macrophages were maintained for 1 month post-SCI. These 
results suggest that the M1 macrophages were responsible for the defective wound 
healing over time. Furthermore, macrophage-conditioned media (MCM) was also 
collected from the supernatant of polarized macrophages to determine the effect of M1 
and M2 MCM on cortical neurons in vitro. The M1 - but not the M2 - MCM was 
neurotoxic to cortical neurons [39]. Consequently, this study suggests that the M1 
macrophages are detrimental to healing. 
On the other hand, M1 macrophages have also been shown to be beneficial for 
wound healing [40]. M1 macrophages are highly angiogenic, stimulating endothelial cell 
sprout formation in vitro and in vivo in part by secretion of vascular endothelial-derived 
growth factor (VEGF) [5, 41]. When M1 macrophages were depleted in a mouse model 
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of skeletal muscle injury via CD11b-diptheria toxin, muscle regeneration was completely 
prevented [42]. In contrast, when M2 macrophages were depleted, muscle regeneration 
was still possible, but it was significantly impaired. However, persistent numbers of M1 
macrophages mark chronic inflammation and impaired healing, highlighting the 
importance of the correct M1-to-M2 sequence in tissue repair. 
 
1.3.3 The role of M2 macrophages in wound healing 
M2 macrophages are generally associated with healing and tissue remodeling of 
the wound and are the dominant phenotype in the proliferation and remodeling stages of 
wound healing [43]. The M2 macrophages are usually responsible for the formation of 
connective tissue [44]. However, the granulation tissue may eventually lead to the 
formation of scar tissue or a fibrous capsule. For this reason, it is believed that the M2 
macrophages contribute to the fibrous capsule formation and the FBR [4].  
The M2 macrophage phenotype can be further classified into three-
subpopulations: M2a, M2b, and M2c [5, 45]. Macrophages are polarized to the M2a and 
M2c phenotype by environmental stimulation of IL-4 and IL-10, respectively (Figure 3b) 
[5, 45]. The M2b phenotype is polarized by toll-like receptors (TLC) or other immune 
complexes [45]. Although the M2b is categorized within the M2 phenotype, the M2b 
macrophages are activated by an inflammatory environmental stimulus more similar to 
that of the M1 macrophages [46]. Their role in wound healing is not known. The 
traditional alternatively activated M2 macrophages are now referred to as the M2a 
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phenotype, which promotes the production of extracellular matrix (ECM) and collagen, a 
necessary part of healing [5, 46]. 
Preliminary studies have attempted to explain the functioning of M1, M2a, and 
M2c subpopulations in wound healing and vascularization [5], however there is still a 
great need for further research in this area. M1 macrophages secrete VEGF to initiate 
angiogenesis. M2a macrophages secrete PDGF, a chemoattractant that stabilizes growing 
blood vessels and promotes anastomosis of new blood vessels into networks [5]. M2c 
macrophages secrete high levels of matrix metalloprotease 9 (MMP-9), a protease that is 
involved in the breakdown and remodeling of the ECM and vasculature [5]. M2c 
macrophages also express high levels of CD163, which has been shown to be associated 
with tissue repair and remodeling of the wound and promoting cell proliferation in mice 
[45]. Thus, it appears that M1, M2a, and M2c macrophages appear sequentially in normal 
wound healing, but more studies are required that distinguish between M2a and M2c 
macrophages in order to confirm this hypothesis. 
 
1.3.4 Role of M1 and M2 macrophages in the FBR to biomaterials  
Surprisingly, it is still not clear which macrophage phenotype is responsible for 
the formation of the fibrous capsule. M1 macrophages are widely believed to be the cause 
of the fibrous capsule as the inflammatory response up-regulates the FBR, thereby 
increasing the thickness of the fibrous capsule [47]. However, IL-4, a cytokine that 
induces the activation to the M2a phenotype, has been shown to promote the formation of 
FBGC, which ultimately causes the formation of the fibrous capsule [5, 48]. 
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To investigate the association of macrophage phenotype and tissue remodeling of 
biological scaffolds in the FBR, Badylak et al. implanted porcine small intestine 
submucosa (SIS), carbodiimide crosslinked porcine derived SIS (CDI-SIS), and 
autologous tissue graft as a control subcutaneously in Sprague-Dawley rats for 1, 2, 4, 
and 16 weeks [49]. Immunostaining of CCR7 and CD163, representing M1 and M2 
markers respectively, showed an infiltration of M2 macrophages in the SIS scaffolds at 
all time points, along with an organized layer of connective tissue at the 16 week time 
point, which suggests constructive remodeling. The CDI-SIS scaffolds were initially 
infiltrated with equal amounts of M1 and M2 macrophages at 2 weeks post-implantation, 
but were eventually dominated by the M1 macrophages at 4 weeks post-implantation 
leading to the formation of FBGC and fibrosis at 16 weeks post-implantation. The 
autologous graft scaffold showed a high level of M2 macrophages at the 1 and 2 week 
time points, but over time, an even distribution of M1 and M2 macrophages was 
observed. At the 16 week post-implantation, less organized collagenous connective tissue 
was also observed.  The authors concluded that biomaterials that promote the M2 
phenotype are associated with constructive tissue remodeling compared to those that 
promote the M1 phenotype [49]. This study was one of the first to suggest macrophage 
phenotype as a predictor of the success or failure of biomaterials. 
 Brown et al. evaluated the effects of 14 FDA-approved biological scaffolds on 
macrophage phenotype and the FBR in rats [50]. All scaffolds were composed of 
naturally occurring material but differed in the source and species of the tissue. The 14 
scaffolds included AlloMax, AlloDerm, Avaulta Plus, CollaMend, Flex HD, InteXen LP, 
MatriStem, PelviSoft, Strattice Firm, Strattice Pliable, Sugisis, SurgiMend, Veritas, and 
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Xenform. Immunohistochemical analysis of CD68, CCR7, and CD206 was performed on 
the samples after 14 and 35 days of implantation to quantify the relative proportions of 
M1 and M2 macrophages at each time point. In general, a higher M2 to M1 ratio was 
associated with more constructive remodeling [50].  
Goreish et al. evaluated the effects of phosphorylcholine (PC) coated biomaterials 
on the FBR and fibrous capsule formation via intramuscular implantation in rabbits for 4 
and 13 weeks, and found that there were less M1 macrophages and a reduced fibrous 
capsule on the PC-coated biomaterial compared to the control of high-density 
polyethylene, but were not significantly different at 4 days post-implantation [51]. At 13 
weeks post-implantation, little to no M1 macrophages were found at the implantation site 
for both control and PC-coated biomaterials. The fibrous capsule thickness of the PC-
coated biomaterial was reduced to no capsule or partial encapsulation at the 13 week time 
point, while the fibrous capsule thickness of the control was thinner but still present [51]. 
This study indicated a direct correlation of inflammatory macrophages to the thickness of 
the fibrous capsule.  
On the other hand, M2 macrophages have also been implicated in the formation of 
the fibrous capsule. M2 macrophages secrete PDGF and TGF-β, known mediators of the 
fibrous capsule [52]. Several studies have shown that IL-4, which causes M2 
polarization, induces the formation of FBGC and subsequently the fibrous capsule [52]. 
A study by Kao et al. implanted a cage system subcutaneously in rats, providing a 
prolonged inflammatory environment [52]. Anti-murine IL-4 (IL-4Ab), murine IL-4 
(muIL-4), normal goal nonspecific control IgG (gtIgG), and PBS were injected into the 
cages and released into the implant site to determine the effects of IL-4 on the FBR.  
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Implants releasing muIL-4 showed a significant increase in the formation of FBGC and 
fibrous capsule compared to the IL-4Ab and controls. The IL-4Ab resulted in a 
significantly decreased formation of FBGC and fibrous capsule compared to the controls 
[52].  
A recent study was designed to directly assess the role of macrophage phenotype 
in vascularization and fibrous encapsulation of tissue engineering scaffolds [5]. Model 
biomaterials chosen to elicit a range of macrophage responses were implanted 
subcutaneously into mice for 10 days. Porous collagen scaffolds were expected to elicit 
an M2 response, LPS-coated scaffolds were expected to elicit an M1 response, and 
glutaraldehyde-crosslinked collagen scaffolds were expected to elicit a mixed M1/M2 
response. Immunohistochemical analysis demonstrated that the unmodified scaffolds 
were surrounded by the highest numbers of M2 macrophages, indicated by three markers 
of the M2 phenotype, coincident with a dense fibrous capsule. The LPS-coated scaffolds 
were infiltrated by high numbers of M1 macrophages, as indicated by three markers of 
the M1 phenotype, but without evidence of fibrous encapsulation. Interestingly, the 
glutaraldehyde-crosslinked scaffolds stained strongly for both M1 and M2 markers, and 
were infiltrated by high numbers of blood vessels, in keeping with the idea that both M1 
and M2 macrophages are required for vascularization [5]. Clearly, more studies are 
required to elucidate the relative contributions of M1 and M2 macrophages to the FBR 
and fibrous capsule formation. 
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1.4 Macrophage polarization in response to biomaterials  
 Understanding of the role of macrophage phenotype on the spectrum from healing 
to fibrous encapsulation will allow us to design biomaterials with macrophages in mind. 
As an initial step toward controlling macrophage behavior, several studies have 
systematically evaluated the response of macrophages to changing biomaterial properties.  
 
1.4.1 Decellularized biological scaffolds  
Decellularized extracellular matrix (ECM) scaffolds have a strong clinical 
potential to mitigate the FBR and to promote wound healing. Decellularized bladder 
ECM has been used to repair damaged skeletal muscle of humans, resulting in the 
formation of new muscle tissue, neovascularization, recruitment of endogenous myogenic 
progenitor cells, and functional recovery [53]. These scaffolds are prepared by removing 
cells and cellular debris from tissues using detergents, often followed by chemical 
crosslinking. Several studies have shown their potential to modulate inflammation in 
comparison to cellular scaffolds. Xu et al. used a primate model to show that 
decellularized scaffolds does not induce significant chronic inflammation or promote a 
severe immune response compared to the cellular scaffolds [54]. These findings are 
supported by the findings of Brown et al., in which the inflammatory response associated 
with decellularized allografts (rat body wall ECM) compared to cellular autograft 
(autologous body wall tissue) and porcine bladder xenografts for 28 days post 
implantation was examined in Sprague-Dawley rats [55]. Immunohistochemical analaysis 
revealed that the cellular scaffolds had a macrophage population that favored the M1 
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phenotype at the majority of time points, associated with a dense, poorly organized 
collagenous response, while the decellularized scaffolds had a macrophage population 
that favored the M2 phenotype, which was associated with neomatrix formation by the 
end of the observation period. Interestingly, only the decellularized scaffolds resulted in 
angiogenesis as early as three days post implantation [55]. Thus, the use of decellularized 
scaffolds to regenerate tissue is an active area of research [56]. 
 
1.4.2 Porosity of biomaterials 
In addition to allowing for ingrowth of tissue and blood vessels, the porosity and 
pore diameter of a biomaterial has been shown to be critical in the FBR [20]. For 
example, Madden et al. showed that porous hydrogel scaffolds promoted a pro-healing 
response compared to non-porous biomaterials in vivo in two different species [20]. 
Microtemplated hydrogel scaffolds were fabricated from poly(2-hydroxyethyl 
methacrylate-co-methacrylic acid) (pHEMA-co-MAA) scaffolds with pore diameters of 
20 - 80µm. Cardiac implantation of the acellular scaffolds of varying pore sizes were 
evaluated for 4 weeks to determine the effects of pore diameter on the formation of the 
fibrous capsule, neovascularization, and the macrophage phenotype profile. The non-
porous scaffolds promoted a more severe inflammatory response indicated by a 
significantly higher expression of the M1 marker iNOS compared to the porous scaffolds. 
Although there was not a significant difference, there was a general increase in the 
expression of MMR, an M2 marker, in the porous scaffolds. In addition, the porous 
scaffolds with larger pores (30 - 60µm in mice and 40 - 80µm in rats) resulted in more 
neovascularization as indicated by significantly higher expression of RECA-1, a marker 
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for endothelial cells, compared to nonporous scaffolds and scaffolds with 20µm pores. At 
the same time, nonporous scaffolds and those with 20µm pores resulted in a significant 
increase in the fibrous capsule thickness. There seemed to be an optimal pore diameter of 
the scaffold, approximately 30-40µm, that reduced the fibrous capsule thickness and the 
number of M1 macrophages, and enhanced neovascularization. Interestingly, the authors 
noted a much higher number of macrophages expressing markers of both the M1 and M2 
phenotype compared to the numbers of more homogenous populations, indicating 
significant contribution of hybrid phenotypes to neovascularization. This study proposed 
that porous biomaterials increase the activation of M2 macrophages, which coincides 
with enhanced vascularization of the biomaterial [20].   
 
1.5 Active control over macrophage phenotype 
 With the recent increase in the number of studies examining the relationships 
between biomaterial properties, macrophage phenotype, and healing outcome, the 
possibility of controlling macrophage behavior for a beneficial response is becoming a 
reality. Strategies are moving away from attempts at inhibition of the inflammatory 
response towards those that actively work with macrophages for therapeutic effects. 
 Preliminary studies of drug delivery strategies that release immunomodulatory 
factors have shown proof-of-concept that macrophages can be harnessed. For example, 
the release of chemotactic factors for macrophages, including monocyte chemoattractant 
protein-1 (MCP1) and agonists of the S1P receptor, cause increased scaffold integration, 
vascularization, and tissue regeneration in cardiac and bone defects [57-59].  Mokarram 
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et al. evaluated the effects of macrophage phenotype manipulation via local delivery of 
immunomodulatory cytokines IFN- γ and IL-4 from agarose hydrogels on peripheral 
nerve regeneration in critical sized 15 mm sciatic nerve gap defects in rats [60].  IFN-γ, 
which promotes the M1 phenotype, or IL-4, which promotes the M2a phenotype, were 
mixed with agarose hydrogel and inserted into a hollow polysulfone tube as a nerve 
guidance channel and were implanted in critical nerve gap of rats for three weeks.  The 
release of IL-4 resulted in a significant increase in the M2 macrophages and enhanced 
Schwann cell migration to the middle of the scaffold compared to the blank control and 
the release of IFN-γ. Furthermore, axon regeneration was observed in the IL-4 samples, 
and the amount of axons in the IL-4 samples was approximately 20 times greater than the 
control and IFN-γ samples. The ratio of M2 to M1 markers was linearly correlated with 
axon regeneration [60].  Controlled release strategies like these show that it is possible to 
control macrophage behavior for beneficial effects on biomaterials.  
 Macrophages are at the center of the FBR and consequently hold the key to the 
success or failure of a biomaterial. We now know that macrophage phenotype plays a 
critical role in determining the therapeutic outcome. More studies are required to 
delineate the roles of macrophage phenotype in the FBR, particularly in fibrous capsule 
formation vs. vascularization and integration, and the roles that biomaterials properties 
like surface structure and pore size play in dictating phenotypic changes. Future 
generations of biomaterials will consider macrophage phenotypic response as an 
important design consideration, and will even control macrophage behavior for beneficial 
outcomes. 
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Chapter 2: Experimental design 
 The overall goal of this study is to design a mathematical model to evaluate 
differences in normal wound healing and in macrophage dynamics in the FBR to 
implanted biomaterials (Figure 4). Understanding how the macrophage profile of a 
chronic wound deviates from normal wound healing is essential because biomaterials can 
then be modified to manipulate the macrophage profile for beneficial results.  
 The specific aims of this work are to: 
1. Design and validate a mathematical model to describe macrophage polarization in 
normal wound healing. 
2. Design and characterize model biomaterials to assess the foreign body response in 
vivo. 
3. Apply the model to determine if the macrophage dynamics surrounding the 
implanted biomaterials differs from those in normal wound healing.  
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Figure 4:  A schematic of the experimental design. A. The development of a mathematical model that models 
macrophages in normal wounding based on in vitro experiments. B. In vitro characterization of crosslinked 
gelatin hydrogels, which were implanted in mice at different time points to evaluate the macrophage phenotypes 
via histology. 
  
2.1 Specific aim 1: Design and validate a mathematical model to describe macrophage 
polarization in normal wound healing 
Specific aim 1 is the development of a mathematical model consisting of three 
ordinary differential equations of M0, M1, and M2 macrophages based on the current 
literature and in vitro experiments to represent the macrophage profile of normal wound 
healing (Figure 4A). 
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 With the risks involved in the implantation of a biomaterial, animal studies are 
usually conducted to prove its safety and efficacy. Initially, in vitro studies are often done 
to obtain preliminary data and as proof of concept. The next logical step in evaluating a 
biomaterial is to use the preliminary data to design in vivo studies. Data from the in vitro 
and in vivo studies are compared side by side to validate the findings and make 
hypotheses of the course of behaviors when implanted into humans. However, it is 
difficult to precisely identify rate constants of macrophage dynamics from animal studies, 
because they are expensive, time-consuming, and cost animal lives. As a result, there is a 
need to develop a mathematical model for biomaterials based on in vitro experiments to 
help predict the in vivo host response, also called the foreign body response, which will 
indicate the overall biocompatibility of the biomaterial [61]. Establishing this model will 
minimize the cost and time it takes to complete a biocompatibility study. Although there 
have been previous mathematical models describing the foreign body response, many of 
these models use parameters that are physiologically irrelevant and/or missing key  
biological concepts, which are critical in the foreign body response [62, 63]. The 
development of a mathematical model based on in vitro studies will help gain a better 
understanding the complex immune system. This knowledge can be used to help better 
design biomaterial devices, implants, and prosthetics to overcome this foreign body 
response without costly and time consuming animal studies. 
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2.2 Specific aim 2: Design and characterize model biomaterials to assess the foreign 
body response in vivo. 
Specific aim 2 is the in vitro characterization of the model biomaterial that can be 
used to assess the in vivo foreign body response at the Shanghai Key Tissue Engineering 
Laboratory and compare the results to normal wound healing (Figure 4B). Gelatin 
hydrogels were chosen as a model biomaterial to evaluate a chronic wound caused by 
biomaterial implantation, which is commonly used as a model chronic wound in rodents 
[64, 65]. Because of the low mechanical properties of gelatin, the hydrogels were 
crosslinked in order to provide mechanical strength, and they were crosslinked to 
different extents in order to determine the effects of crosslinking on the foreign body 
response.  The gelatin hydrogels were chemically crosslinked with glutaraldehyde (GA) 
to increase the mechanical stiffness. GA was chosen to chemically crosslink the 
hydrogels because of its ability to effectively react and bond with the primary amine 
groups of proteins [64, 66, 67]. Gelatin, derived from collagen, has multiple primary 
amine groups readily available for chemical crosslinking. The hydrogels were crosslinked 
at three different GA concentrations of 0.3, 0.1, and 0.05% in order to examine the effect 
of mechanical stiffness on the macrophage profile in vivo. Before the hydrogels could be 
analyzed in vivo, they were characterized by the hydrogel properties including the 
crosslinking density, mechanical properties, degradation, and swelling in order to 
determine any significant difference between the different concentrations of GA 
crosslinking.  
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2.3 Specific aim 3: Apply the model to determine if the macrophage dynamics 
surrounding the implanted biomaterials differs from those in normal wound healing.  
Specific aim 3 is to assess the in vivo foreign body response in terms of the 
macrophage profile and the fibrous capsule surrounding the implanted hydrogels. The 
three different crosslinked hydrogels were implanted into C57BL/6 mice subcutaneously 
at three different locations per mouse at the different time points with a replica of six 
mice (n=6) per time point. The locations of the three hydrogels for each mouse were 
chosen in such a way that the concentrations of the hydrogels were in different positions 
for each replicate.  
 Immunostaining and Massson’s trichrome staining were used to identify 
macrophage phenotypes and fibrous capsule thickness, respectively. Masson’s trichrome 
stain is currently the standard to stain for the fibrous capsule as it stains collagen blue. 
The thickness of the fibrous capsule was quantified via Image J. Immunohistochemistry 
(IHC) was also performed to stain for the M1 and M2 macrophage phenotypes. Each 
sample was analyzed for the surface markers iNOS (M1 macrophages), and Arg1 and 
CD163 (M2 macrophages). IHC of the three surface markers stain the respective 
macrophages brown after development with 3,3’-diaminobenzidine (DAB).  The intensity 
of brown staining was also quantified via Image J to determine the amount of 
macrophage staining in each sample. Correlation analyses were performed on the 
thickness of the fibrous capsule and the intensity of macrophage staining. Finally, the 
macrophage profiles of these biomaterial-induced chronic wounds were compared to that 
of normal wound healing, derived from the mathematical model developed in Aim 1. 
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Chapter 3: Specific Aim 1 
Aim 1: Design and validate a mathematical model to describe macrophage polarization in 
normal wound healing. 
 
3.1 Background and derivation 
3.1.1 Existing mathematical models 
A recent study by Yang et al. was conducted to mathematically model the profile 
of fibroblasts, macrophages, chemoattractants (TGF-B), debris cell population, and ECM 
production using five ordinary differential equations, which were dependent on time [63]. 
This study also conducted in vivo animal studies to compare the experimental data with 
the mathematical model [63]. However, only fibroblasts and macrophages were tested in 
vivo, and did not test for the production of ECM, measurement of debris population, and 
chemoattractants. Thus, there was no comparison of the experimental data (ECM, debris, 
and chemoattractants) to the developed mathematical model. Even though the modeling 
of fibroblasts, macrophages, and collagen/ECM is important and relevant to the foreign 
body response, the model did not distinguish between the different macrophage 
phenotypes of M1 or M2, which are essential in the foreign body response.  Modeling of 
the M1 and M2 macrophages and performing histology to quantify the collagen 
production would have made this mathematical model more accurate and physiological 
relevant. 
 Another study by Wang et al. developed a mathematical model for macrophage 
activation in left ventricular remodeling in post-myocardial infarction [62]. In this 
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mathematical model, the M0, M1, M2, and three cytokine productions (IL-10, TNF-a, IL-
1) were modeled using six ordinary differential equations [62]. These equations are more 
physiologically relevant because it took into account the different macrophage 
phenotypes and the transitions from the M1 to M2 phenotype. However, many of these 
parameter values were estimates derived from other models that may not be relevant and 
were not based on any in vitro or in vivo experiments. In addition, immunostaining of the 
different macrophage phenotypes in post-myocardial infarction was not performed 
resulting in no comparison to any experimental data to validate the model. The 
macrophage profile in post-myocardial infarction may or may not be different from that 
of normal wound healing. Macrophage staining should have been performed in this study 
for verification. 
 
3.1.2 Biology of mathematical model 
A mathematical model of the macrophage profile in normal wound healing was 
established by developing three ordinary differential equations (ODE) to describe the 
three main macrophage populations (M0, M1, M2), influenced by understanding of 
macrophage biology. Based on the current literature, it is known that there are tissue 
resident macrophages residing in the body [68]. In response to an injury, circulating 
monocytes derived from the bone marrow are recruited to the injury site and differentiate 
into unactivated macrophages (M0) [69]. The initial inflammatory response and 
environmental stimulus polarizes the M0 to the M1 phenotype resulting in a relatively 
high amount of M1 during the early stage of wound healing. As the inflammatory phase 
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diminishes and the wound heals over time, the M1 decreases while the M2 begins to 
accumulate. During the wound healing process, the macrophages are either removed from 
the system to the lymph nodes [38] or die at the wound site, which is called the death 
rate. The accumulated macrophages eventually migrate to the draining lymph nodes 
returning back to the pre-injury state of resident macrophages after the wound is 
completely remodeled and healed [68].  
 
3.1.3 Criteria for mathematical model 
Based on the known temporal sequence of macrophage appearance and 
disappearance following injury, the successful mathematical model of the macrophage 
profile must meet these specific criteria:  
1. A cellular infiltration of M1 macrophages initially dominates the early stage of wound 
healing representing the inflammatory response with a peak about 3-5 days post-injury 
[36, 42]. 
2. Following the inflammatory response, the M2 macrophages accumulate, eventually 
dominating the M1 macrophages, which represents the proliferation and remodeling 
stages of wound healing, with a peak at approximately 10 days [37, 70]. 
3. Macrophage accumulation levels return back to pre-injury state of resident 
macrophages after the wound the completely healed and remodeled [68]. 
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3.1.4 Assumptions 
Some assumptions were made in order to simplify this model: 
1. The rate constants were calculated from the rate of polarization, transition, or 
proliferation at particular time points from experiment of primary human macrophages 
cultured in vitro. The rate constants were assumed to be the same throughout the wound 
healing process.  
2. Only the M2 macrophages proliferate, which has been shown before [37] and which 
we also found, in that the increase in the cell viability from day 3 to day 6 was only seen 
in the M2 population [76].  
3. The only source of M1 and M2 macrophages is the polarization of M0 or the transition 
of M1 to M2. 
4. M1 and M2 macrophages do not dedifferentiate back to the M0 macrophages because 
environmental stimuli are constantly present. 
5. M2 macrophages do not transition back to M1 macrophages.   
6. The macrophage profile is only representative of recruited macrophages and not 
resident macrophages. The baseline of 0 macrophages is indicative of resident 
macrophages. 
 
3.1.5 Mathematical model derivation 
 The rate of macrophage accumulation is governed by the following general 
equation:  
                                       (1)  
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Based on the macrophage biology described above, the input of this system is the 
polarization or transition from the initial population that enters the system, while the 
output is polarization to a different phenotype and the death rates of each population, and 
the generation term represents the rate of proliferation of the macrophages. The net rate 
of the three terms equals the rate of accumulation, which represents the change in the 
amount of macrophages of each phenotype at any given point in time.  
Rate equations were formulated to describe macrophage polarization to a new 
phenotype. The rate equations are given by the following:  
   
  
→        (2) 
   
  
→        (3) 
   
  
→        (4) 
  
  
→         (5) 
where k1 is the rate at which M0 polarizes to the M1, k2 is the rate at which M0 polarizes 
to the M2, k3 is the rate at which M1 polarizes to the M2, k4 is the self-proliferation rate 
of M2, and pM2 is the proliferated M2 macrophages. Equations 2-4 can be rewritten in 
terms of differential equations: 
   
  
          (6) 
   
  
                              (7) 
   
  
                             (8) 
where equation 6-8 represent the rate of M1 polarization from M0, rate of M2 
polarization from M0, and rate of M2 transition from M1, respectively. 
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From the rate equations and the death rates obtained from the in vitro 
experiments, the rates of the inputs and output of each phenotype were derived. More 
specifically, the macrophages within the M0 population will either polarize to the M1 or 
M2 phenotype. Thus, the output is the rate at which the M0 polarizes to M1 or M2 or the 
removal of the M0 macrophages to the lymph node/cell death, derived from (2) and (3), 
is: 
                                    (9) 
where d0 is the death rate constant of M0 population. Similarly, the surviving 
macrophages within the M1 population will transition to the M2 phenotype. The output 
of M1, derived from (4), is: 
                               (10) 
where d1 is the death rate constant of M1 population.  
 The output of the M2 population is given only by the death rate: 
                     (11)  
where d2 is the death rate constant of the M2 population. 
The input of M0 is the migration of macrophages from the circulating blood from 
the body to the wound site (D). 
                         (12) 
The input of the M1 population is the rate at which the surviving M0 macrophages are 
polarized to the M1, derived from (2): 
                       (13) 
The input of M2 is the rate at which the surviving M0 polarizes to the M2 and the 
surviving M1 transition to the M2, derived from (3) and (4): 
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                            (14) 
Both the M0 and M1 populations do not consist of a generation term because both 
of these macrophage populations were assumed to not proliferate based on the fact that 
there was no observable proliferation in the in vitro experiments. The generation of the 
M2 is the proliferation rate of the surviving M2 population, derived from (5).  
                       (15) 
where k4 is the proliferation rate constant of the M2 population.  
The mathematical model is a closed system of a specific amount of macrophages 
at the initial conditions, which represent the amount of macrophages that are recruited to 
the system. Since it is assumed that the M1 and M2 macrophages originate from the M0 
macrophages, the initial conditions of M1 and M2 are zero, and only the M0 are recruited 
or migrate to the system at t=0.  
The rate of accumulation or amount of macrophages for each population can be 
computed by combining the terms according to (1). Thus, the rates of change of M0, M1, 
and M2 are shown below: 
   
  
                              (16) 
   
  
                            (17) 
   
  
                                  (18) 
These three ordinary differential equations were modeled using ode45 function in 
MATLAB.  
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3.2. Methods 
3.2.1. In vitro experiments for mathematical model 
 Data for the mathematical model were derived from previously published in vitro 
experiments by our group [76] (reproduced below for clarity), and were used to 
determine physiologically relevant parameters and their respective values. Unactivated 
and polarized macrophages were characterized by cell viability and flow cytometry. 
 
3.2.1.a Cell viability of macrophage phenotypes 
Briefly, monocytes were isolated from leukocyte fraction of human peripheral 
blood using sequential Ficoll and Percoll density gradient centrifugation, as previously 
described [5]. Monocytes were cultured in at 37ºC and 5% CO2 in ultra-low attachment 
flasks in complete media with macrophage colony stimulating factor (MCSF) for 5 days 
to differentiate to unactivated macrophages (M0). M0 macrophages were seeded and 
cultured at a density of 1.0x10
6
 cells/ml at day 0. Macrophages were polarized over the 
next 1-6 days via IFN-γ and lipopolysaccharide (LPS) for M1 and IL-4 and IL-13 for M2, 
with M0 as control and a change in media at day 3. During the media change, MCSF, 
M1, and M2 polarizing media was added to its respective phenotype. In addition, the 
media of the M1 group switched to M2 polarizing media in order to determine the rates 
that the macrophages transition [5]. Cell viability of the macrophages was determined at 
each day via trypan blue exclusion. Macrophages at each time point were characterized 
by expression of M1 (CCR7) and M2 (CD206) surface markers via flow cytometry.  
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3.2.1.b. Flow cytometry of macrophage phenotypes 
The initial condition values were obtained from the in vitro experiment explained 
above [76]. Thus, the initial condition values for M0, M1, and M2 are 1.0x10
6
, 0, and 0 
cells, respectively. The macrophage saturation was determined to be the same value as 
the initial condition of M0 so that the total amount of macrophages cannot exceed the 
initial amount of macrophages recruited, simplifying the model. Other parameter values 
were also calculated from flow cytometry and cell viability analysis. M1 and M2 
macrophages were identified by the surface marker expression of CCR7 and CD206, 
respectively. To describe the change in the numbers of cells representing the M1 and M2 
populations, the data has been gated based on the mean intensities of CD206 and CCR7 
expression of the M0 population at the same time point. In order to determine the number 
of macrophages in each population, cells were described as CCR7
hi
CD206
lo
, which 
would indicate the M1 phenotype, and as CCR7
lo
CD206
hi
, indicative of the M2 
phenotype. The percentage of macrophages expressing each marker was calculated based 
on these thresholds. Macrophages in each population that were not CCR7
hi
CD206
lo
 or 
CCR7
lo
CD206
hi
 were considered to be M0 macrophages.  
 
3.3 Results 
3.3.1 In vitro experiments for mathematical model 
3.3.1.a Cell viability of macrophage phenotypes 
The cell viability of the macrophage populations is reported as the fold change 
over the initial concentration (Table 1, Figure 5) [76]. A decrease in the macrophage 
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populations was observed from day 1 to day 3 indicating cell deaths within each 
population. At day 3, the media was changed replenishing the nutrient uptake. The 
number of M0 and M1 macrophages leveled off from day 4 to day 6. However, an 
increase in the M2 macrophages was observed from day 4 to day 6, which indicates 
proliferation. Therefore, it was assumed that only the M2 macrophages proliferate, which 
is in agreement with recent publications [37]. 
 
Table 1: The raw data of the cell viability of the concentration (cells/mL) of each macrophage population [76] 
 
 
 
Cell Viability 
(10
6
 cells/mL) 
M0 M1 M2 M1 -> M2 
Day 1 1 0.95 1 N/A 
Day 2 0.566 0.633 0.666 N/A 
Day 3 0.6 0.49 0.255 0.49 
Day 4 0.4 0.326 0.17 0.733 
Day 6 0.458 0.333 0.625 0.575 
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Figure 5: Cell viability calculated by the fold change over day 0 of each macrophage population [76] 
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Table 2: The raw data of flow cytometry as reported as the percentage of positive cells that express M1 or M2 
characteristics for each macrophage phenotype [76] 
 
 
 
% Positive 
Cells 
Macrophage 
Phenotype 
M0 CCR7
hi
/CD206
1o 
(M1) 
CD206
hi
/CCR7
lo 
(M2) 
Day 0 M0 59.31 3.09 37.6 
Day 1 M0 62.59 7.51 29.9 
M1 52.95 42.3 4.75 
M2 52.65 4.65 42.7 
Day 2 M0 56 14 30 
M1 58.49 33.2 8.31 
M2 46.6 12.9 40.5 
Day 3 M0 52 31 17 
M1 55.88 34.8 9.32 
M2 33.7 26.8 39.5 
Day 4 M0 63.6 11.1 25.3 
M1 37.36 61.4 1.24 
M2 11.28 0.82 87.9 
M1 -> M2  72 13.1 14.9 
Day 6 M0 61.1 11.4 27.5 
M1 35.53 63.6 0.863 
M2 36.15 6.75 57.1 
M1 -> M2  21.61 1.09 77.3 
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3.2 Determination of parameter values 
To calculate the death rates, the cell viability and the percent expression of the 
marker from flow cytometry were multiplied for a more accurate representation of the 
expression of each of the surviving macrophage population. Cell viability provides 
information about the size of the population but does not indicate the phenotypic 
distribution within that population. On the other hand, flow cytometry indicates the 
phenotype expression, but does not show the cell survival or death from each time point. 
Therefore, the product of the two, termed the survival expression, gives a better 
representation of the rates of each of the macrophage population (Table 3). The values of 
death and proliferation rates constants were determined by first calculating the rate or 
slope of the survival expression at day 1 to day 3 of the respective macrophage 
population as seen in equation 19, as an approximation of the rate at day 1. This rate was 
then divided by the initial population at day 1 of the respective phenotypes in order to 
calculate the rate constant. For example, d0 was calculated by the following steps: the 
A B 
Figure 6: The macrophage expression of M1 and M2 characteristics in flow cytometry [76] 
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quantity of the difference of the survival expression of the M0 population from day 1 to 
day 3 was divided by the quantity of the difference in time, in this case, from day 1 to day 
3. The rate constant d0 is determined by dividing the calculated rate/slope by the 
population of M0 at day 1. d1 and d2 were calculated similarly, but within the M1 and 
M2 populations, respectively.  
The rate of change or the slope is calculated in the following equation: 
 
  
 
                                         
                
                           (19) 
Similarly, the M2 proliferation rate was also calculated using the survival expression 
from day 3 to day 6.  
The rates of macrophage polarization from M0 to M1 and M2 were determined by 
the survival expression of the phenotype when initially stimulated with cytokines at day 
0. The rate of change of the amount of macrophages expressing the phenotype from day 0 
to day 1 was determined to calculate the polarization rates. Similarly, the transition rate 
from M1 to M2 was determined by the following steps. The rate of change of the increase 
in survival expression of M2 macrophages and the rate of change of the decrease in the 
survival expression of M1 macrophages of the M1 -> M2 group from day 3 to day 6 were 
calculated and averaged to obtain the M1 to M2 transition rate.  
The rate constant k1 was calculated using a similar method to that of the death 
and proliferation rates by first determining the rate of polarization from day 0 to day 1 
using equation 6.  The difference between the survival expression of CCR7
hi
CD206
lo
 of 
the M0 population at day 0 and the survival expression of CCR7
hi
CD206
lo
 of the M1 
population at day 1 was calculated and dividing by the quantity by the difference in time, 
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in this case, from day 0 to day 1, as an approximation of the rate of polarization at day 1. 
The resulting calculation is the rate of M1 polarization from M0. From equations 6, k1 
was calculated by dividing the rate of M1 polarization by the average population of M0 at 
day 1. The average population of day 0 and day 1 was chosen because the rate was 
calculated between these two time points was not measured in flow cytometry or cell 
viability. Similarly, the rate constant k2 was calculated by determining the rate of M2 
polarization from the M0 population using equation 7. The difference between the 
expression of CCR7
lo
CD206
hi
 of the M0 population at day 0 and the expression of 
CCR7
lo
CD206
hi
 of the M2 population at day 1 was calculated and dividing that quantity 
by the difference in time. From equation 7, k2 was calculated by dividing the rate of M2 
polarization by the average population of M0 between day 0 and day 1. This time period 
was chosen because the M1 and M2 cytokines were added at time 0 to polarize the M0 
macrophages to each phenotype, and they appear to be fully differentiated at the next 
time point, based on flow cytometry data.  
To calculate the M1 to M2 transition rate constant k3, the rate of increase in the 
expression of CCR7
lo
CD206
hi
 of the M2 population and the rate of decrease in the 
expression of CCR7
hi
CD206
lo
 of the M1 population were averaged from day 3 to day 6 
using equation 8. The proliferation of M2 rate constant k4 was determined by calculating 
the rate of the survival expression of CCR7
lo
CD206
hi
 of the M2 population from day 3 to 
day 6. Day 3 was chosen as the initial time point because the M2 macrophages appeared 
to start proliferating at this time, based on cell viability data. 
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Table 3: The survival expression of each of the macrophage populations 
 
 
 
Survival 
Expression 
(cells) 
Macrophage 
Phenotype 
M0 CCR7
hi
/CD206
1o
 CD206
hi
/CCR7
lo
 
Day 0 M0 59.31 2.93 37.6 
Day 1 M0 62.59 7.13 29.9 
M1 52.95 40.18 4.75 
M2 52.65 4.41 42.7 
Day 3 M0 31.2 18.6 10.2 
M1 27.3 17.0 4.56 
M2 8.59 6.83 10.0 
Day 6 M0 28.0 5.22 12.6 
M1 11.8 21.2 0.28 
M2 22.5 4.21 35.6 
M1 -> M2 12.4 0.626 44.4 
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Table 4: The rate constants that were calculated by the survival expression term 
 
 
 
Death and 
proliferation rate 
constants 
Value (day
-1
) 
d0 (day 1 to day 3) 0.156 
d1 (day 1 to day 3) 0.121 
d2 (day 1 to day 3) 0.163 
k4 (day 3 to day 6) 0.0853 
 
Table 5: The polarization and transition rates of each of the macrophage population 
 
 
 
Polarization and transition rates Value (per day) 
k1 (day 0 to day 1) 0.611 
k2 (day 0 to day 1) 0.0836 
Decrease M1 (M1 -> M2, day 3 to day 6) 0.114 
Increase M2 (M1 -> M2, day 3 to day 6) 0.0547 
k3 (M1 -> M2, day 3 to day 6) 0.0846 
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Table 6: List of all the parameters with its respective values of the mathematical model 
 
 
 
Parameter Description Value Source 
D M0 migration to wound site 0.015 cell/day [63] 
d0 M0 death rate 0.156 /day Figure 5, 6 
d1 M1 death rate 0.121 /day Figure 5, 6 
d2 M2 death rate 0.163 /day Figure 5, 6 
k1 M0 transition to M1 0.611 /day Figure 5, 6 
k2 M0 transition to M2 0.0836 /day Figure 5, 6 
k3 M1 transition to M2 0.0846 /day Figure 5, 6 
k4 M2 proliferation 0.0853 /day Figure 5, 6 
 
The M0, M1, and M2 macrophage profiles of normal wound healing were 
modeled in MATLAB using ode45 (Figure 7).  
 
3.3.3 Results: Model of macrophage profile in normal wound healing 
Upon injury or the start of the model, the majority of the M0 macrophages are 
polarized to the M1 phenotype while some to the M2 phenotype because the M0 
macrophages are mainly exposed to inflammatory cytokines and environment. According 
to the model, the M1 macrophages rapidly increase and peak at day 5 post-injury, but 
gradually decrease afterwards. The early infiltration of the M1 macrophages is required 
for clearance of wound debris. After day 5, the M1 macrophages transition to the M2 
phenotype representing a switch to the pro-healing or anti-inflammatory stage of wound 
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healing. The M2 macrophages, from the start of the injury or model, gradually increase 
and accumulate and are eventually the dominant phenotype in the system. In addition to 
the polarization of M0 to M2 and the transition of M1 to M2, the M2 macrophages also 
proliferate. The macrophages at this stage are responsible for tissue regeneration and 
remodeling. After the wound is remodeled and healed, the macrophages return back to 
the pre-injury level of resident macrophages. Thus, this model accurately represents the 
macrophage profile observed in normal wound healing [36, 70, 71]. 
 
 
 
 
 
Figure 7: The output of the model representing M0, M1, and M2 macrophage profile in normal wound healing. 
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Chapter 4: Specific Aim 2 
Aim 2: Design and characterize model biomaterials to assess the foreign body response in 
vivo. 
4.1. Design criteria 
 The criteria for this specific aim is to determine the concentration of GA required 
to crosslink the gelatin hydrogel that would result in hydrogel properties that are 
statistically different such as the stiffness. The crosslinked hydrogels were characterized 
by four different properties in order to determined significant differences between the 
hydrogels. The four characterization properties include mechanical stiffness, degradation, 
swelling, and crosslinking density.  
4.2 Methods 
4.2.1. Preparation of glutaraldehyde and glycine 
Glutaraldehyde (25% stock solution) from Sigma Aldrich was diluted with 
phosphate buffer saline (PBS) to 0.05%, 0.1%, and 0.3% concentrations. 0.1 M glycine 
(Sigma Aldrich) was made by dissolving 0.225 g of glycine in 30 mL of sterile PBS. The 
glycine solution was then sterilized via heating and UV light for at least 2 hours. 
 
4.2.2 Preparation of sodium citrate and sodium phosphate 
 Sodium citrate (Sigma Aldrich) was made by dissolving 2.94 g of sodium citrate 
tribasic in 1000 mL of DI water. The pH was of the solution was adjusted to 6.0 by 
adding approximately 200 uL of 37% hydrochloric acid. 0.5 mL of Tween-20 (Sigma 
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Aldrich) was added to the solution and mixed well. Sodium phosphate (Sigma Aldrich) 
was made by dissolving 1.2 g of sodium phosphate monohydrate in 1000 mL of PBS and 
adding 0.1 mL of Tween-20. 
 
4.2.3. Preparation of crosslinked gelatin hydrogels 
10 wt% gelatin was made by heating and dissolving 4 g of gelatin (Sigma 
Aldrich, Type B bovine skin) in 40 ml of PBS. 8 mL of the gelatin solution was 
transferred into petri dishes and allowed to cool to room temperature. The petri dishes 
were placed in a refrigerator or ice bucket in order for the gelatin to completely solidify. 
Once solidified, a 5 mm biopsy punch was used to punch the gelatin into cylindrical 
disks. The gelatin hydrogels were crosslinked by immersion in 0.05%, 0.1%, and 0.3% 
GA solutions in a shaker overnight. The crosslinked gelatin hydrogels were then 
sterilized under UV light for at least 2 hours. The hydrogels were then washed 4 times in 
PBS for 15 minutes each wash. Afterwards, the hydrogels were put into 0.1M glycine 
solution in a shaker overnight to neutralize any residual GA. The hydrogels were washed 
an additional two times in PBS for 15 minutes each. Again, the hydrogels were sterilized 
under UV light for at least 2 hours. 
 
4.2.4 Hydrogel characterization 
4.2.4.a Mechanical testing and Young’s modulus of hydrogels 
 The crosslinked gelatin hydrogels were mechanically tested via compression tests 
in order to determine the effects of crosslinking. The force and displacement data were 
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obtained via Bose Electroforce 3100 Test Instrument of Drexel University for each of the 
hydrogel samples. Using a caliper, the dimensions, the height and the diameter, of the 
hydrogels were measured. The hydrogels were compressed to 30% strain at a rate of 
0.333 per second. The stress and strain were calculated, and the slope of the initial linear 
region, about 5-7% strain, was used to determine the Young’s modulus.  
 
4.2.4.b Degradation of gelatin hydrogels  
 Crosslinked hydrogels were immersed for one week in collagenase (Sigma 
Aldrich) to monitor enzymatic degradation. The concentration of collagenase was 5 
ug/mL. The initial mass of the hydrogels were measured, and then the hydrogels were 
massed every 24 hours after blotting dry on a paper towel to determine the percent mass 
loss over time. 
 
4.2.4.c Swelling ratio of hydrogel 
 The swelling ratio of the hydrogels was calculated by the following equation:  
                
     
  
    (20) 
where ws is the swollen weight and wd is the dry weight. The swollen weight was 
calculated by measuring the mass of the hydrogels after allowing them to reach 
equilibrium after swelling in PBS overnight. The hydrogels were then allowed to dry at 
room temperature in order to measure the dry weight.  
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4.2.4.d Crosslinking density of hydrogels 
 The crosslinking density of each hydrogel was calculated by the modified Flory 
Rehner equation [72]: 
 [  (    )        
 ]
        
 
  
  
 
 
      (21) 
where ε is the crosslinking density, vp is the polymer volume fraction, χ is the polymer-
solvent interaction parameter, ρ is the density of the polymer, and V1 is the molar volume 
of solvent. vp was calculated by the measuring the dimensions of the hydrogels. χ was 
determined via literature search [72]. The density of the hydrogel was calculated by 
measuring the mass of the hydrogel divided by the volume of the hydrogel. V1 was 
calculated by determining the molar mass of H2O. The crosslinking density was 
calculated with the given parameters from experiments (vp, ρ ) and literature. 
 
4.2.5 Statistical analysis 
 Statistical analysis was performed in MATLAB using one-way ANOVA with 
Tukey post hoc analysis in order to determine statistical significance between the 
crosslinked hydrogels. 
4.3 Results 
4.3.1 In vitro hydrogel characterization  
 The crosslinked gelatin hydrogels were characterized by mechanical testing, 
degradation, swelling, and crosslinking density. As seen in the figures below, the values 
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obtained for the hydrogels of the three different crosslinking concentrations were 
statistically different from each other in each of the experiments. 
 
 
 
 
 
 
Figure 8: The crosslinked hydrogels characterized by the hydrogel properties. A. The crosslinking density of 
each hydrogel is significantly different. B. The stiffness of each hydrogel is significantly different. C. The 0.3% 
hydrogel was significantly different from the other two hydrogels. D. The degradation of each hydrogels were 
significantly different from day 7 to day 13. *  indicates statistical significance (p<0.05) between the indicated 
groups. ** denotes p<0.01, *** denotes p<0.005, **** denotes p<0.001 
 
A B 
C D 
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As expected, the crosslinking density of the hydrogels increased as the concentration of 
GA increased. From the ANOVA analysis, the three hydrogels (0.5%, 0.1%, and 0.3%) 
were statistically significant from each other with p < 0.05. Similarly, the Young’s 
modulus of the hydrogels increased with increasing crosslinking, and the hydrogels were 
all significantly significant from each other. The swelling ratio of the hydrogels 
decreased with increasing crosslinking, which has been shown before [72]. With a 
network of crosslinks, hydrogels cannot absorb as much water compared to less 
crosslinked hydrogels, thus reducing the swelling of the hydrogels. The swelling ratio of 
both the 0.05% and 0.1% crosslinked hydrogel was significantly lower than that of the 
0.3% crosslinked hydrogel. The 0.05% and 0.1% hydrogels were statistically similar. In 
addition, the rate at which the hydrogels degraded decreased with increasing crosslinking. 
The hydrogel crosslinked at a higher concentration resulted in a slower degradation 
because of more crosslinks and bond formed within the network structure.  
Chapter 5: Specific Aim 3 
Aim 3: Apply the model to determine if the macrophage dynamics surrounding the 
implanted biomaterials differs from those in normal wound healing. 
 
5.1. Experimental design 
 Three crosslinking concentrations were chosen to represent biomaterials with 
high, medium, and low crosslinking. Consequently, the crosslinking of the hydrogels 
affects the hydrogel properties including degradation, swelling, and mechanical stiffness. 
The 0.05, 0.1, and 0.3% GA crosslinked hydrogels were determined to be statistically 
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different in crosslinking density, mechanical stiffness, degradation, and swelling ratio 
from each other. Thus, these hydrogels can be implanted subcutaneously in mice to 
assess the FBR in response to the different biomaterial properties. Each of the three 
hydrogels was implanted subcutaneously at three different location of the back of one 
mouse in order to avoid the difference in immune responses of different mice. A replica 
of 6 (n=6) mice was used to determine statistical significance. In addition, the three 
hydrogels in each mouse were implanted at three different time points of 3 days, 10 days, 
and 3 weeks. The three time points were chosen to assess the FBR of a chronic wound 
over time representing the inflammatory stage, the proliferative stage, and the remodeling 
stage. 
 
5.2 Methods 
5.2.1 In vivo implantation subcutaneously in mice 
All animal experiments were conducted in accordance with the local ethical 
committee of Shanghai Jiao Tong University. C57BL/6 6-8 week old male mice were 
ordered from Shanghai 9
th
 People’s Hospital. The mice were anesthetized with choral 
hydrate and shaved prior to surgery. The hydrogel samples were implanted 
subcutaneously in the mice. Three incisions were made on each mouse with scissors to 
implant the three different concentrations of crosslinked gelatin hydrogels (Figure 10). 
The first incision was made at the top of the back body, right below the neck. The second 
incision was made on the left side of the back body, next to the left back legs. The third 
and final incision was made on the right side of the back body, next to the right back legs. 
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After each incision, a pocket was made under the skin with forceps. The wound was 
sutured together after the hydrogels were implanted. The mice were monitored daily to 
observe for any signs of infections or abnormalities. Six mice (n=6) were used for each 
time point.  
 
 
 
 
Figure 9: A schematic of the locations in which the crosslinked hydrogels were implanted subcutaneously per 
mice. A hydrogel with different crosslinking concentration was implanted for each location. 
 
5.2.2 Explanting and paraffin embedding samples and sectioning 
Explanting and paraffin embedding was performed at Shanghai Key Tissue 
Engineering Laboratory of Shanghai Jiao Tong University. Sectioning was performed at 
Kimmel Cancer Center (KCC) of Thomas Jefferson University. After each timepoint (3 
days, 10 days, and 3 weeks), the mice were euthanized and the hydrogels were explanted. 
Upon explanting, the hydrogels were attached to the skin by the fibrous capsule around 
the hydrogel. The hydrogels and the surrounding tissues were cut and immediately fixed 
in 4% (PFA) for 24 hours. Once fixed, the hydrogels were washed for 8 hours in PBS. 
The samples then underwent dehydration and xylene replacement through an alcohol and 
xylene series to remove any water remaining in the sample. The samples were then 
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embedded in a block of hot paraffin and allowed to cool overnight. Each sample 
embedded in paraffin was placed in ice for 30 minutes prior to microtome sectioning for 
smoother sectioning. The samples were then sectioned at 5 um. Two different sections of 
each sample were put on glass slides for staining. 
5.2.3 Histological analyses 
 The sectioned samples were prepared for histological analyses including H&E, 
Masson’s trichrome, and IHC staining. Once the fibrous capsule and macrophage 
expression were quantified, correlation analyses were performed to determine the 
relationships between the macrophage phenotype and the fibrous capsule. 
 
5.2.3.a Deparaffinization of sectioned samples 
The sectioned samples on the slides were put on a slide rack and placed in an 
oven at 70C for 45 minutes to melt the paraffin wax. The slide rack was then immediately 
immersed in 100% CitriSolv (Sigma Aldrich) for 5 minutes. The slide rack was then 
immersed in the following order and duration: 100% CitriSolv for 5 minutes, 100% 
CitriSolvfor 5 minutes, 100% ethyl alcohol for 1 minute, 100% ethyl alcohol for 1 
minute, 95% ethyl alcohol for 1 minute, 95% ethyl alcohol for 1 minute, and 80% ethyl 
alcohol for 1 minute. The slides were then rinsed with water. 
 
5.2.3.b H&E staining 
After deparaffinization of the samples, the slide rack was immersed in a solution 
of hematoxylin (Sigma Aldrich) for 3 minutes. The slides were then rinsed in a water 
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bath, followed by immersing the slide rack in a hydrochloric acid/alcohol mixture (Sigma 
Aldrich) for 1-3 seconds. Next, the slides were immersed in a water bath for 20 minutes. 
The slides were dipped in eosin (Sigma Aldrich) for 15 seconds. The slides were then 
dehydrated again through an ethanol series. Lastly, two drips of Permount (Sigma 
Aldrich) and a cover slip was added to preserve each of the sectioned samples. 
 
5.2.3.c Masson’s trichrome staining 
 Masson’s trichrome kit was purchased from Sigma Aldrich. After 
deparaffinization of the samples, the tissue samples in the slide rack were re-fixed in 
Bouin’s solution for 1 hour at 56 °C and were washed in running tap water for 7 minutes 
to remove the yellow color afterwards. The samples were then immersed in hematoxylin 
solution for 1 minute and were washed in running warm tap water for 10 minutes. The 
samples were rinsed in deionized (DI) water and immersed in Biebrich scarlet-acid 
fuchsin solution for 13 minutes. The samples were washed again in DI water and 
differentiated in a solution of phosphomolybdic-phosphotungstic acid for 20 minutes or 
until the collagen was not stained red. The samples were transferred directly to aniline 
blue solution for 12 minutes and rinsed with DI water. Afterwards, the samples were 
immersed in 1% acetic acid solution for 5 minutes and rinsed in DI water. To preserve 
the samples using Permount, the samples were dehydrated through a series of ethyl 
alcohol concentrations and CitriSolv as described above. Two drops of Permount and a 
coverslip were added to preserve the stained samples.    
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5.2.3.d Immunohistochemistry staining 
 After deparaffinization of the samples, antigen retrieval was performed in order to 
unmask and expose the antigen site from the crosslinks when fixed with PFA. The 
samples were immersed in 10mM sodium citrate (Sigma Aldrich) and placed in a 
microwave and heated until boiling. The samples were kept in the solution inside the 
microwave for 20 minutes and were cooled to room temperature and washed with 
running tap water afterwards. BLOXALL solution of the ImmPress Excel staining kit 
(Vector Laboratories) was added in order to block any endogenous peroxide in each 
sample. The samples were then washed in the buffer 2x for 5 minutes each.  2.5% normal 
horse serum was added and incubated for 20 minutes to block the samples. The primary 
antibodies iNOS (Abcam, rabbit anti-mouse), Arg1 (Santa Crus Biotechnology, goat anti-
mouse), and CD163 (Santa Cruz Biotechnology, rabbit anti-mouse) were added to the 
samples and incubated overnight at 4 C. The samples were washed 2x in buffer solution 
for 5 minutes each. The ImmPress Excel secondary antibody (horse anti-rabbit or horse 
anti-goat) was then added to the samples and incubated for 45 minutes. The samples were 
washed 3x in buffer solution for 5 minutes each. DAB reagent 1 and DAB reagent 2 was 
mixed together to make the final DAB solution. Following the wash, DAB was added to 
the samples with the same amount of time for each sample. The samples were washed in 
the buffer solution for 2x for 5 minutes each and then rinsed in tap water. The samples 
were immersed in hematoxylin as a counterstain for about 10 seconds and were washed 
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in running tap water for 5 minutes. The samples were dehydrated through a series of 
ethanol and Citrisolv and coverslipped as described above.    
 
5.2.4 Imaging and quantification 
 All stained samples were imaged via the EVOS microscope. MATLAB was used 
to quantify the H&E, and Image J was used to quantify Masson’s trichrome, and IHC 
staining. A MATLAB code was programmed to automate the quantification of the 
fibrous capsule of the H&E stains. The fibrous capsule from Masson’s trichrome stain 
and macrophage expression from IHC were quantified at the hydrogel-tissue interface of 
both the left and right sides of the hydrogel. To quantify the fibrous capsule in the H&E 
and Masson’s trichrome stain, a line was drawn from the edges of the fibrous capsule, 
and the length (in pixels) was measured. The value in units of pixels was converted to um 
based on the magnification of the image. To quantify the macrophage expression, the 
polygon selection tool in ImageJ was used to draw a small section at the interface. The 
pixel intensity within the section was measured to determine the macrophage expression. 
Sections of approximately equal area were drawn on the top and bottom of the hydrogel 
for each side, resulting in a total of 4 different regions in each section, and two sections 
per sample. Negative controls were included for each IHC experiment as a baseline for 
comparison. 
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5.2.5 Statistical analysis 
Data are reported as mean   standard deviation (SD). Statistical analysis was 
performed in MATLAB using one-way ANOVA with Tukey post hoc analysis on in vitro 
characterization experiments in order to determine statistical significance. A two-way 
ANOVA with Tukey post hoc analysis was performed on the in vivo histological 
stainings to determine statistical significance. A p-value of less than 0.05 was considered 
significant. Student t-test was performed to determine statistical significance between the 
left and right side of the hydrogel. Correlation analyses were conducted to determine any 
relationships between the macrophage phenotype and the fibrous capsule thickness.  The 
Pearson’s correlation coefficient was calculated at 2-tailed 95% confidence interval.  
 
5.3. Results 
5.3.1 Histological and correlation analyses 
5.3.1.a H&E staining and quantification 
 In H&E stains, the cell nuclei were stained blue, while the cell cytoplasm was 
stained red or pink. The blue layer of cells deposited at the hydrogel to tissue interface 
was determined to be part of the fibrous capsule or the foreign body response. Therefore, 
each image was quantified by measuring the thickness of this outer layer surround the 
hydrogels. 
The fibrous capsule was quantified through a multi-step imaging process in 
MATLAB as illustrated figure 11. Initally, the H&E images were captured via the EVOS 
microscope at 4x magnification and were stitched together to recreate the entire sample. 
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The RGB images were converted to binary based on the threshold of the pixels at the 
hydrogel-tissue interface. Isolated pixels were filtered to reduce the background noise. 
Neighboring pixels with gaps or hole were filled in order to connect the missing pixels at 
the interface. All background noises were then removed, and the area this interface was 
calculated. The perimeter of the interface was also calculated by shrinking the width to a 
line and determining the length of the line. To calculate the thickness of the fibrous 
capsule, the total area was divided by the perimeter or the length of the total sample. 
 
 
 
 
 
Figure 10: A MATLAB code that quantifies the fibrous capsule via image processing. 
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In order to verify that the output of the MATLAB code was a good representation 
of the actual thickness of the fibrous capsule, the pixels of a zoomed in image at 20x 
magnification of the fibrous capsule was manually measured in ImageJ. The MATLAB 
code did in fact give an accurate representation of the actual fibrous capsule as illustrated 
in figure 12. 
 
 
 
  
 
Figure 11: The thickness of the fibrous capsule was measured in ImageJ to verify the MATLAB quantification. 
 
The thickness of the fibrous capsule was imaged and measured for each time 
point and crosslinking concentration (Figure 14 and 15). In general, an increase in the 
fibrous capsule thickness was observed with increasing crosslinking concentration and 
time. A two-way ANOVA analysis revealed that there was statistical significance 
between values at each time point, but no statistical significance between the crosslinking 
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concentrations. Figure 13 illustrates the general representation of the H&E images of the 
samples.  
 
 
 
 
Figure 12: A labeled H&E image to illustrate the infiltration of cell surrounding the hydrogel. 
 
Hydrogel 
Fibrous 
Capsule 
Tissue 
64 
 
 
 
 
 
Figure 13: H&E images showing the difference in fibrous capsule of the 3 crosslinked hydrogels at the 3 time 
point 
 
Table 7: The MATLAB quantification of the fibrous capsule from the H&E images  
 
 
 
Fibrous Capsule 
Thickness  
0.05% 0.1% 0.3% 
3 days 18.2 8.27 23.9 6.69 26.6 3.00 
10 days 35.9 7.85 38.2 5.53 39.8 5.88 
3 weeks 45.9 2.24 46.1 5.23 51.3 13.0 
 
 
3 days 
10 days 
3 weeks 
0.05% 0.1% 0.3% 
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Figure 14: Graphical representation of the thickness of the fibrous capsule quantified using the MATLAB code 
from H&E images. * denotes p<0.05, *** denotes p<0.005. 
 
The fibrous capsule thickness increases with time, which is consistent with the 
current literature in chronic wound of implanted biomaterials. However, the fibrous 
capsule is mainly composed of collagen, which is not quantifiable in the H&E staining. 
Therefore, another staining method was utilized to verify the fibrous capsule thickness 
from the H&E staining. 
 
5.3.1.b Masson’s trichrome stain 
 The Masson’s trichrome is the standard staining method to quantify the fibrous 
capsule as it stains collagen blue and nuclei red or pink. Similar to the H&E stains, the 
thickness of the fibrous capsule was quantified at the hydrogel-tissue interface as 
illustrated in figure 16A and 16B. The fibrous capsule was quantified by imaging each 
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sample at 20x magnification and measuring the fibrous capsule via ImageJ. Both the cell 
nuclei and collagen at the site of the interface was measured as the fibrous capsule as 
indicated in figure 17. From the H&E stains, it was observed that there were differences 
on the left and right sides of the interface of the hydrogels. As a result, the fibrous 
capsule on both sides of the hydrogel-tissue interface was quantified to determine any 
physiological difference between the muscle and skin side of the implant.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The fibrous capsule was quantified for the three crosslinked samples at each time point 
(Figure 20). On both sides of the hydrogel, there was no observable trend in the fibrous 
Muscle 
Tissue 
Hydrogel-tissue  
interface 
Hydrogel 
A 
Tissue 
Hydrogel 
Hydrogel-tissue  
interface 
B 
Figure 15: Labeled Masson’s trichrome image to illustrate the collagen and infiltration of cells around 
the hydrogels 
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capsule thickness between the three different crosslinking concentrations. Student’s t-test 
was performed to compare the thicknesses of the left and right sides of the hydrogels. The 
analysis revealed no statistical significance between the two sides. Thus, the thicknesses 
of the two sides were averaged for further analysis. A two-way ANOVA analysis 
indicated that there was statistical significance as to the effect of time, but no statistical 
significance was observed from the crosslinking concentration. The fibrous capsule 
thickness was significantly thicker at the 3 week time point compared to the 3 and 10 day 
time points, while the 10 day time point was significantly thicker compared to the 3 day 
time point. The increase in the fibrous capsule thickness can be visually seen over time as 
illustrated in figures 16, 17, and 18.  
 
 
 
 
Figure 16: A 4x magnification of the Masson’s trichrome stain of a 3 day 0.1% hydrogel zoomed in to a 20x 
magnification at both sides of the hydrogel 
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Figure 17: A 4x magnification of the Masson’s trichrome stain of a 10 day 0.1% hydrogel zoomed in to a 20x 
magnification at both sides of the hydrogel 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
Figure 18: A 4x magnification of the Masson’s trichrome stain of a 3 week 0.3% hydrogel zoomed in 
to a 20x magnification at both sides of the hydrogel 
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Figure 19: Masson’s trichrome images at 10x magnification showing the difference in fibrous capsule of the 3 
crosslinked hydrogels at the 3 time points. 
 
 
 
 
 
 
3 days 
10 days 
3 weeks 
0.05% 0.1% 0.3% 
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Table 8: Masson’s trichrome quantification of the fibrous capsule thickness on both sides of the hydrogel (units 
are in um) 
 
 
 
Fibrous 
Capsule 
Thickness  
3 days 10 days 3 weeks 
Mean  
SD 
0.05% 0.1% 0.3% 0.05% 0.1% 0.3% 0.05% 0.1% 0.3% 
Left 32.1  
10.4 
35.3  
11.4 
30.3  
10.7 
46.7  
14.3 
46.7  
16.1 
49.8  
7.79 
96.5  
23.3 
81.8  
30.3 
95.3  
21.0 
Right 32.5  
9.88 
31.9  
10.6 
29.9  
6.09 
50.2  
7.96 
44.8  
6.65 
54.6  
13.2 
84.0  
18.1 
64  
5.4 
82.6  
25.2 
Mean 24.8  
9.71 
25.9  
10.6 
22.1  
8.44 
34.9  
11.2 
32.7  
12.2 
39.2  
10.5 
66.2  
20.9 
50.4  
22.7 
67.7  
23.1 
 
 Both the Masson’s trichrome and H&E stains indicated that there was statistical 
significance in the thickness of the fibrous capsule between each time point, but no 
significance in the thickness of the fibrous capsule between the crosslinking 
concentrations. However, a student t-test indicated that the fibrous capsule quantified 
from the Masson’s trichrome stain was significantly higher than the fibrous capsule 
quantified from the H&E stain for all samples except the sample of 0.3% at 3 day time 
point (Figure 21). The Masson’s trichrome stain is a better quantification of the fibrous 
capsule because this methods stains for collagen, which makes up the fibrous capsule, 
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whereas H&E only stains for cell nuclei. Therefore, values obtained from Masson’s 
trichrome were used for further analysis.  
 
 
 
 
 
 
 
Figure 20: The comparison between the fibrous capsule thickness quantified from H&E and the fibrous capsule 
thickness quantified from Masson’s trichrome. * denotes p<0.05, *** denotes p<0.005. 
 
5.3.1.c Macrophage phenotyping by immunohistochemistry 
 IHC was performed on each sample and stained for specific surface markers to 
identify the M1 and M2 macrophages. The M1 macrophages were indicated by iNOS 
staining, while M2 macrophages were indicared by Arg1 and CD163 staining. In order to 
A 
B 
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determine real staining from background staining, negative and positive controls samples 
were included each time IHC experiment was performed. Sections of mouse spleen were 
used as the positive control. The difference in staining between the negative and positive 
controls is portrayed in figure 22.  Samples with higher expression of macrophage 
markers result in dark brown stains as seen in the mouse spleen. When quantifying 
intensity of RGB images, darker pixels have lower values than lighter pixels. Therefore, 
to convert the values to values that are proportional to the darkness of the stain, and thus 
the intensity of macrophage marker expression, the intensity of a sample was divided by 
the intensity of the negative control, representing fold change over the negative control. 
This value is then subtracted from 1 so that darker stains have higher values. 
 
 
 
 
Figure 21: The negative and positive controls of an IHC stain. 
 
The intensity of each surface marker was evaluated at four different locations, the top and 
bottom of the left and right sides of the hydrogel. A Student’s t-test was performed to 
Negative Control Positive Control 
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indicate there was no statistical difference between the two sides. Thus, the expression of 
iNOS on both sides was averaged for further analysis to give a fair representation of the 
marker expression in each sample (Figure 23).  
 
 
 
 
 
Figure 22: The intensity of the IHC staining was quantified within the yellow rectangular boxes. 
 
Although the analysis showed that there was a slight decrease in the iNOS 
expression from the 3 day time point to the 3 week time point, it was not statistically 
significant. However, it was interesting to note that the post hoc analysis showed a 
significant difference in the iNOS expression of the 0.05% and 0.1% concentration, while 
there was no statistical significance between the 0.05% and 0.3% or between the 0.1% 
and 0.3% for all time points. As expected, samples at all time points resulted in high 
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expression of iNOS indicating an infiltration of M1 macrophages throughout the 
experiment (Figure 24). The data showed that there is a constant presence of the M1 
macrophage indicating a chronic inflammation, which deviates from the M1 profile of 
normal wound healing in which the numbers of M1 macrophages subside after 5 days. 
 
 
 
 
 
Figure 23: iNOS staining quantification at 20x magnification of the 3 crosslinked hydrogels at the 3 time points. 
 
Similarly, the expression of both M2 markers Arg1 and CD163 was quantified on 
both sides (Figure 25 and 26), which were not statistically different. With the average of 
the both sides, a two-way ANOVA analysis was conducted to determine the effect of the 
crosslinking and time. For the M2 surface markers, there was no statistical difference of 
3 days 
10 days 
3 weeks 
0.05% 0.1% 0.3% 
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the Arg1 and CD163 expression between the crosslinked hydrogels. However, there was 
a statistical difference in the marker expression of both markers with respect to time. The 
marker expressions at the 3 week time points were significantly higher than that of both 
the 3 day and 10 day time points. The marker expressions at the 10 day time points were 
significantly higher than that of the 3 day time point. It seems that the M2 macrophage 
profile behaves similar to that of mathematical model of normal wound healing in that the 
M2 macrophage slowly proliferate initially and accumulates over time. However, more 
time points in the in vivo study are needed to determine how the M2 macrophages behave 
after the 3 week time point in a chronic wound. 
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Figure 24: Arg1 staining quantification at 20x magnification of the 3 crosslinked hydrogels at the 3 time points. 
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Figure 25: CD163 staining quantification at 20x magnification of the 3 crosslinked hydrogels at the 3 time 
points. 
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Figure 26: The quantification of the fibrous capsule thickness and the macrophage phenotype. A. Quantification 
of the thickness of the fibrous capsule. B. Quantification of iNOS staining. C. Quantification of Arg1 staining. D. 
Quantification of CD163 staining. * denotes p<0.05, *** denotes p<0.005 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A B 
C D 
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Table 9: Quantification of the intensities of the three surface markers  
 
 
 
Intensity 
of 
Stain 
3 days 10 days 3 weeks 
Mean
  
SD 
0.05% 0.1% 0.3% 0.05% 0.1% 0.3% 0.05% 0.1% 0.3% 
iNOS 0.537
  
0.055 
0.634
  
0.068 
0.581
  
0.032 
0.531
  
0.034 
0.576
  
0.039 
0.546
  
0.043 
0.518
  
0.069 
0.604
  
0.059 
0.563
  
0.055 
Arg1 0.351
  
0.051 
0.358
  
0.064 
0.378
  
0.061 
0.415
  
0.045 
0.436
  
0.027 
0.450
  
0.030 
0.570
  
0.041 
0.607
  
0.058 
0.586
  
0.038 
CD16
3 
0.318
  
0.043 
0.276
  
0.103 
0.294
  
0.093 
0.335
  
0.105 
0.341
  
0.045 
0.329
  
0.073 
0.493
  
0.038 
0.481
  
0.032 
0.479
  
0.050 
 
The ratio of M1:M2 indicated which macrophage phenotype is dominant at each 
time point. A ratio greater than 1 implies a dominant M1 or inflammatory phenotype, 
whereas, a ratio less than 1 implies a dominant M2 phenotype. Since there are two M2 
markers, both iNOS:Arg1 and iNOS:CD163 ratios were calculated and averaged because 
both surface markers followed the same trend of increasing intensity expression over 
time. The M1:M2 ratio decreased over time, with the M1 phenotype initially dominating 
at the early time points and the M2 phenotype dominating at later time points. 
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Table 10: M1:M2 ratio to indicate the macrophage phenotype at each time point  
 
 
 
M1:M2 ratio 3 days 10 days 3 weeks 
 0.05% 0.1% 0.3% 0.05% 0.1% 0.3% 0.05% 0.1% 0.3% 
iNOS:Arg1 1.52 1.76 1.53 1.27 1.32 1.21 0.908 0.996 0.960 
iNOS:CD163 1.69 2.29 1.97 1.58 1.68 1.65 1.05 1.25 1.17 
Mean SD 1.60  
0.113 
2.03  
0.374 
1.75  
0.311 
 
1.43  
0.214 
1.50  
0.258 
1.43  
0.315 
0.979  
0.100 
1.12  
0.183 
1.06  
0.152 
 
The IHC staining revealed that the macrophage profile of a chronic wound due to 
biomaterial implantation deviated from that of normal wound healing. Unlike normal 
wound healing, the M1 macrophages surrounded the hydrogels throughout the 3 week 
study. The quantification of the M1 macrophages showed a relatively high expression of 
iNOS at all time points, indicating chronic inflammation. However, the M2 macrophage 
profile followed a similar course of behavior compared to that of normal wound healing. 
Initially, there was a low expression of Arg1 at the early time point. The expression of 
Arg1 progressed with time. Similar to normal wound healing, the M2 macrophages 
slowly surrounded the hydrogel over time and eventually accumulated. The results seem 
consistent with the idea of a chronic wound in that a prolonged inflammatory response 
exists due of the presence of the implanted hydrogel. 
  
5.3.2 Correlation Analyses 
 Correlation analyses were performed to determine any relationships between the 
macrophage phenotype and the fibrous capsule thickness (Figure 28). The correlation 
analysis revealed a strong negative relationship between the M1:M2 ratio and the 
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thickness of the fibrous capsule with a Pearson’s correlation coefficient of -0.836. This 
suggests that a lower M1:M2 ratio or a M2 dominant phenotype correlates with a thicker 
fibrous capsule. The correlation analysis also indicated a very weak relationship between 
iNOS and the thickness of the fibrous capsule with a Pearson correlation coefficient of -
0.295. In contrast, there was a strong positive relationship between the M2 surface 
markers, Arg1 and CD163, and the thickness of the fibrous capsule with a Pearson 
correlation coefficient of 0.948 and 0.959, respectively. These correlation analyses 
suggest that the M2 macrophages, not the M1 macrophages, are responsible for the 
increase in the fibrous capsule thickness. 
 
 
 
 
Figure 27: The correlation analyses to the fibrous capsule thickness. A. The correlation between the M1:M2 
ratio and the fibrous capsule. B. The correlation between the iNOS intensity and the fibrous capsule. C. The 
correlation between the Arg1 intensity and the fibrous capsule. D. The correlation between the CD163 intensity 
and the fibrous capsule. 
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Table 11: Correlation coefficients of the M1:M2 ratio and iNOS, Arg1, and CD163 to the fibrous capsule 
thickness 
 
 
 
Correlation to the fibrous capsule thickness Correlation Coefficient, r 
M1:M2 ratio -0.922 
iNOS -0.295 
Arg1 0.948 
CD163 0.959 
 
Chapter 6: Discussion 
 Many models have attempted to explain the behavior of macrophages in normal 
wound healing. However, these models do not include accurate macrophage biology 
experiments, either in vitro or in vivo, to support or justify their parameters resulting in 
physiologically irrelevant or incomplete results [62, 63]. The mathematical model 
described in this work has several advantages over the existing models because this 
model takes into account accurate macrophage profile behavior in normal wound healing. 
In addition, the parameter values in this model are based on in vitro experiments making 
this model more physiologically relevant to the foreign body response in vivo. Other 
studies chose parameter values that would best fit the model, which would then require 
uncertainty and sensitivity analyses. In contrast, this model does not require these 
analyses because the parameters were based on experimental data from macrophages 
cultured in controlled environments. This model was able to model the M0, M1, and M2 
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macrophage population during a period of 30 days. The macrophage profiles were 
consistent with the current macrophage biology of normal wound healing similar to the 
studies by Troidl et al. [70, 71]. Likewise, these studies showed a M1 dominant 
phenotype 3-5 days post-injury and an M2 dominant phenotype afterwards. 
Some limitations to this mathematical model include the fact that it only models 
macrophages in wound healing and does not taking into account of other important cell 
types such as fibroblasts. In addition, the polarization and transition rate constants were 
assumed to be the same throughout the wound healing process, which may not be the 
case at each time point or stages of wound healing. Furthermore, the migration of M0 rate 
to the wound site was based on literature and is not as accurate as performing 
experiments to obtain the value. The macrophages also do not return back to pre-injury 
levels because the macrophage profiles reached an equilibrium in the system. Because the 
newly arriving M0 macrophage rate is incorporated, it offsets the death rates, 
consequently leading to a steady state over time in the system. Most importantly, the in 
vitro experiment was done three times with a replica of 1. For each experiment, each of 
the macrophage population followed a similar trend indicating a good representation of 
the macrophage profiles in vitro.  However, the time points were only taken at an interval 
of 1 day. As a result, the rate constants were calculated from the slope of its respective 
time points, which does not take into consideration of the macrophage profiles in between 
the time points at each day. A possible solution to obtain a better representation of the 
macrophage profile in between each time points is to implement a curve fitting model to 
the data points. Consequently, the in vitro experiment should be repeated to include more 
time points at a smaller intervals in order to obtain the M0 migrate rate, accurately 
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describe the macrophage dynamics, and to confirm the results from this study. And 
because of the limited data available from the in vitro experiments, the polarization rates 
were only approximations of the actual rates. More time points are needed throughout the 
study to more accurately determine the values of each parameter. Although there are 
some drawbacks to the mathematical model, it does describe the macrophage profile in 
wounds reasonably well.  
To represent a chronic wound in the mathematical model, the transition from M1 
to M2 was deleted from the system of equations (Figure 29), which has been suggested as 
the mechanism of wound healing impairment in chronic wounds [73]. In the “chronic 
wound” model, the M1 macrophages dominate throughout the experiment representing a 
chronic inflammation, which was also observed in the IHC staining of the implanted 
hydrogels as well. Even though there was a greater amount of M1 macrophages than the 
M2 throughout the 30 days, the model describes the M1 macrophages decreasing after the 
initial peak at day 3, which was not observed in the IHC staining of the in vivo 
experiment. The IHC staining showed a constant infiltration and amount of M1 
macrophages throughout the 3 week time frame, which was not predicted from the 
“chronic wound” model. Furthermore, the M2 population in this model decreases from 
the original model. This was also not observed in the IHC staining in the in vivo 
biomaterial implantation study, as there were increasing M2 macrophages from the day 3 
to week 3.  This indicates that either this “chronic wound” model does not accurately 
represent macrophage response to biomaterial implantation, or biomaterial implantation 
affects macrophage behavior in other ways besides the M1 to M2 transition.  
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Figure 28: A comparison of a chronic wound via deletion of the M1-to-M2 term to the normal wound healing 
model 
  
The roles of the different macrophage phenotypes in the FBR are still 
controversial and not well understood. The M1 phenotype that is responsible for the 
inflammatory response has been associated with formation of the fibrous capsule [47, 
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51], while the M2 phenotype has been often associated with wound healing and tissue 
remodeling [49, 50]. However, the results from the present study and others [52] have 
showed that the M2 phenotype may be more responsible for the formation of the fibrous 
capsule than the M1 phenotype. Although the M1 phenotype contributes to the 
inflammatory response and the FBR, the M2 phenotype is known to secrete cytokines 
such as PDGF-BB and TGFB that directly promote recruitment of fibroblast, which may 
lead to the formation of fibrotic tissue and eventually the fibrous capsule [5, 52, 74]. To 
gain a better understanding of the FBR, in vivo animal studies were conducted in order to 
compare the macrophage profile of a chronic wound of an implanted biomaterial to that 
of normal wound healing. Gelatin hydrogels crosslinked with GA were chosen as a model 
biomaterial to examine the roles of macrophage phenotypes in the formation of the 
fibrous capsule and the FBR.  The characterization of the hydrogels showed that the each 
of the crosslinked hydrogels were significantly different form each other in terms of 
mechanical stiffness, swelling, degradation, and crosslinking density.  
The IHC staining and quantification of iNOS, Arg1, and CD163 surface markers 
also showed similar results, which revealed that crosslinking had no effect on the cellular 
infiltration of M1 and M2 macrophages. Interestingly, these properties did not result in 
differences in the FBR or the thickness of the fibrous capsule. The crosslinking of the 
hydrogels increases the mechanical stiffness, which has been shown to increase 
macrophage activation thereby inducing a more severe FBR [75]. On the other hand, 
some studies have showed that chemical crosslinking does not induce any detrimental 
effects in vivo in terms of the FBR and biocompatibility [65].  More importantly, studies 
have shown that GA crosslinking is not cytotoxic to fibroblasts and even promote 
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vascularization when implanted subcutaneously in rodents [67]. Hydrogels crosslinked 
with GA have shown to be non-cytotoxic when washed at least two times after the 
crosslinking process [67]. The gelatin hydrogels that were crosslinked at a higher GA 
concentration resulted in higher stiffness, but no effect was observed in the FBR or the 
thickness of the fibrous capsule. In addition, the initial sterilization of the crosslinked 
gelatin hydrogels under UV light for 2 hours prior to implantation could have further 
crosslinked all the hydrogels. It is speculated that the UV light may have contributed to 
further crosslinking the hydrogels increasing the mechanical properties of the hydrogels, 
which would account for the statistically similar results of the in vivo study. However, 
further experiments are required to support this theory. 
The M1 macrophages were strongly stained for iNOS at all time points indicating 
an infiltration of M1 macrophages throughout the study. The constant presences of the 
hydrogels in the body cause the macrophages to become frustrated as they cannot 
phagocytose or degrade the foreign material causing chronic inflammation in the wound. 
Both the Arg1 and CD163 quantification revealed that there was weak staining at 3 day 
post-implantation, mild staining at 10 day post-implantation, and strong staining at 3 
week post-implantation. Although this may seem to follow the behavior of M2 
macrophage profile in normal wound healing, more time points are needed to determine 
the dynamics of the M2 macrophages between each of these time points and after 3 
weeks. From these results, a chronic wound from implantation deviates from normal 
wound healing in that the M1 macrophages are constantly present and infiltrating the 
foreign material.  
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At 3 days post-implantation, the amount of M1 macrophages is almost twice the 
amount of the M2 macrophages. At 3 week post-implantation, there is almost an equal 
amount of M1 and M2 macrophages as evidence by a ratio of approximately 1. Although 
the correlation analyses show that the M1:M2 ratio was strongly negatively correlated 
with the fibrous capsule thickness, the M1:M2 ratio also indicated that M1 phenotype 
was dominant throughout the study indicating that the M1 also contributes to the fibrous 
capsule. Furthermore, the correlation analyses of the expressions of Arg1 and CD163 
showed a strong positive relationship with the fibrous capsule thickness. However, the 
M1 phenotype could be the initiating factor that causes the formation of the fibrous 
capsule because the fibrous capsule was already formed at 3 days post-implantation 
which coincides with a dominant M1 phenotype, and because M1 macrophages transition 
into M2 macrophages. The M2 phenotype would further increase the fibrous capsule by 
secreting PDGFBB and TGFB [74]. However, more studies are needed to elucidate the 
controversies surrounding the macrophage phenotypes and FBR and the formation of the 
fibrous.   
Future studies of this current work include incorporating more time points and the 
effects of different crosslinking density and degradation rate of the biomaterials in the in 
vivo study to gain a more thorough understanding of the inflammatory response to 
biomaterial implantation. In addition, the mathematical model can be applied to other 
conditions or situations by manipulating the variables and parameters based on in vitro or 
in vivo experiments. Furthermore, the model can be made more sophisticated by 
modeling different cell types including fibroblasts and neutrophils, which are also 
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important in wound healing. Other model biomaterials could also be used to determine 
whether the macrophage profiles follow the same trends as the present study. 
 
Chapter 7: Conclusions 
 
 A mathematical model was developed, which successfully modeled the M0, M1, 
and M2 macrophage population in normal wound healing based on in vitro experiments. 
The model was able to accurately represent the macrophage dynamics in normal wound 
healing. In vivo studies were also done to assess the FBR of a chronic wound by 
implanting crosslinked gelatin hydrogels in mice subcutaneously. Hydrogels were 
crosslinked to different extents to determine any difference in the FBR to the mechanical 
stiffness and degradation rate of the hydrogels. After three different time points chosen to 
fall within the stages of the initial inflammatory response, the transition between the 
stages of wound healing, and a pro-healing stage, the hydrogels were explanted for fixed 
for further analyses. Histology including H&E, Masson’s trichrome, and IHC staining 
was performed on each sample post-implantation and determined that there was a chronic 
presence of M1 macrophages throughout the study, deviating from normal wound 
healing. The M2 macrophages were found to contribute to the increase in the fibrous 
capsule thickness. The modulation of the macrophage profile in a chronic wound could 
potentially reduce the FBR and the formation of the fibrous capsule. 
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